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ABSTRACT
Potentiation of inhibitory synaptic transmission mediated by -y-aminobutyric acid
(GADA) acting at the GABA type A (GABAA) receptor is inc reasin gly fC!-!.mlcd :IS ,I
primary site of action for anesthetic d rugs. GAllA ... receptors across rJillcfCm brain
regions can have a different protein subunit cllmpositinn. wh ich inll uclIccs the
pharmacological sensitiv ity of the recepto r complex . The lntruvcucus genera l anesthetic
propo fol is frequently combined with henzorJiazcpines, aud there nrc reports o r synergtsm
in the production of anesthesia. However . the nature of this intcmctinn is unknown. The
purpose of this study was theref ore to ex amine the imcracuon between pmporlll lind the
benzo diazepine receptor agonist Ilurazepamat the receptor level. In nddithm, preliminar y
studies on the influence of subunit compos ition o n the potentiation o f GABA., receptor
function by propofol have been carried our. Two-elec trode vohngc-clamp recording " I'
GABA-activated membrane cu rrents were performed in XI!IIOfllf.~ 11/(' 1';.\' Il11Cytcs
expressi ng human recombinant GABA" receptors .
Propofo l was found to produce similar potentiation o f GABA (3 I,M ) rec eptor-
activa ted currents in receptors composed of a d32'Y1I. and a lJ!'YR subunits . I'ror llrll l
appears to incre ase the aflinity of GABA... receptors for GAUA without c1lO1ngin,!: the
maximal curre nt . In co ntrast. proporo l potentiation or GAnA cun ene W,IS inllue nced by
the 'Y2Lsubunit. Receptors composed of CX2(31subunits were porcnriatcdto a greater extent
than receptors composed of 0I1Pl'Y2I. subunits. The time course of Oll nA., receptor
desensitization can be described by a doub le expone ntial function. Prop lllhi was found
to reduce receptor dcsensnizanon by significantly prolonging the slow time constant of
current decay, resulting in a large increase in the steady-state current activated by a high
GABA concentration.
The interaction between propofol and flurazcpam was examined in receptors
composed of a.fJiY21. (x = I or 2) subunits. Currents activaled by GADA (3-30 pM) were
potentiated hy [owconcentra tions ofpropofot (0.5~10 14M)plus fJurazepam (0.25 and 0.5
JtM) to levels which were significantly greater than expected from an additive response.
At higher concentrations of propofol (20 /!M) or flurazcpam (l pM) the potentiation of
GA13A receptor-activatL'1I currents was nor diffe rent than expected from an additive
response. The bcnzudinzcpinc receptor partial inverse agonist R0 15-4513 was found 10
nhuljsh the Ilur azepnm potentiation of GAAA·aclivated membrane currents without
affecting the propnfo! response. Zopiclone, a cyclopyrrolone derivative which is
classified us a full agonist at benaodiazepine receptors, did not produce the same greater
than additive interaction with propofoJ. In fact, zopielone (l00 nM) combined with
propnlul (1-10 pM) produced an enhancement of the GABA current which was
significantly less than the expected additive response.
These results suggest thai propofol has multiple effects on GABA" receptor
function: An increase in the affinity of the receptor for GADA plus a decrease in receptor
ocscnsluzauon at higher GADA concentrations. The type of exsubunit contained in the
receptor docs not appear 10have a major influence on the ability of propotot to modulate
GAllA" receptor function. However, propofol was significantly less effect ive in the
presence of a Y~L subunit. Thus similarly to many other mcdutarors, potentiation of
iii
GABAA receptor function by propofol does exhibit subunit dependence . S)· llc ,.~i~m
observed clinica lly by lhe comtnnauon of propofol or propoful plus bcuzodiazcpiues can
be exp lained by an interact ion m the receptor level. In addititltllO i llc re:\~ in,\: the afl'inil)'
for GABA. tlurazepam increased the affi nity of the receptor for prupoful, re~ll ll i l1~ ill a
greater than expected potentiation of GABA" receptor function. This intcmction bCI\\'l'Cl1
propofol and benzodiazcplnes was not duc to simple potentiation 01 GAnA~ recepuu'
activity. since zopiclone failed 10 prod uce the supra-additive effect when etllllhilled with
propofol.
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1,0 Introduct ion
v-Amlnobutyrlc acid (GADA) Is the mO~1 abundant intnhirory neunumnsmiucr
substance in the central nervous system (CNS). Almost 30% of lhe neuronal cells in
brain. mainly the small intemeurons are considered to he GABA-ergie. t.c. usc GAllA
as their neurotransmitter substance (9). The most wel l studied furcuou of synaplic,lIly
released GABA is to hyperpolarize postsynaptic neurons. GADA also J"I I:IY~ all impnnant
role as a neurotransmitterand/ or paraerineeffector10 regulatea variety (Ifphysiulugkal
mechanisms in the periphery (43), but a discu5.sion of these effec ts is beyond the senflC
of this thesis. GADA was firs t identified10 be a constituent nf the eNS in 1950. IhllUgh
it wasfirst synthesized in 1883. GADA has been found 10 have major rules, both direct
and indirect, in a host of neur ological and psychiatric disorders.
A review of the amino acid transmitter shows (14), GADA is synthesized in the
presynaptic nerve terminal by o-decarboxylarion of L-glulamic acid hy theenzyme GAl)
(glutamlc acid decarboxylase) . High concemrarions or GAD arc found in CNS gmy
matter. A very good correlation has beenfound belween the tocateauon of' the enzyme
GAD and GABA in the tissue. GAD is known to be tightly hound to its co-rector
pyridoxal phosphate. but structural analogs of glutamate. sul fhydryl rcngcnts, thilll
compounds, anions andadenine nucleotidescan promote dissociationfir hlock lISsOcj,l lilln
of the co-factor resulting in the inhibition of enzyme activity . GAllA is found In he
present in high concentrations in brain and spinal cord, but it is also present in trace
amounts in peripheral nervous tissues. GABA is mainly metabol izedhy transamination
in presence of the e nzyme GABA-transaminase (GABA-T), wh ich is prim arily localized
in mitochondria. In hrain G ADAis also actively taken up inru presynaptic nerve e ndings
by a sod ium depen dent re-uptake me chanism .
The effects of GADA are med iated thr ough a set of recep tors which are classified
as GADA" and GABAs rece ptors. GASAn receptors are coupled to G-proteins which
decrease calcium o r increase potass ium conductances. GABAn receptor s are stimulated
hy baclofen (14).
GASA" rece ptorson the othe r hand are essentially ligand gated chloride channels.
GADA... receptors are competit ively blocked by bicuc ulline. T he GADA...and GAS Aa
receptors arc located both pr e- and postsynaptically o n most neu rons (9) . The inhibitory
effect of GADA acting at GADA... receptors in the eNS results from an increase in
membrane conductance. T he hyperpolarization (and in some cases depolarizalion) of
neurons is produced by an incr ease in membrane permeability to c hloride and bicarbonate
ions (14 ).
1. 1 St ructure and pharmacology of GADA...receptors
T he GADA" receptor is includ ed in the superfamily of ligand gated ion channels,
which includes the nicotinic acetylc holine receptor , serotonin receptor subtype 3 and
g lycine receptors. Members o f this family have a high degree of similarity in amino-acid
sequences (61). GADA...rece ptorshave a hetero-oligome ric structure comp osed of peptide
subunits wh ich form s an integral ion cbannel and the extracellular domain of the receptor
comprises binding sites for GABA and other pharmaco logical modulators (77). Within
a very short time (in lime scale o f microseconds) o f release From the nerve lenniml. the
neurot ransmitter GABA binds 10 me GABAA receptor protein comp lex and triggers a
conformational change in the receptor st ructure. The change in configuration opens :111
aqueous pore across the membrane resulting in the now of ions :lllmg their
electrochemical gradient (90).
Electron microscopic studies of isolated porcine cort ical GABAA receptorsshow
a pentamerlc structure o f the rec eptor protein complex with ace ntra l water filled pore
which is a characterist ic feature of ligand gated ion channels (59). Determinat ionof the
molecul ar structure of the GABA A receptor was done with photoatTinily hlhclling hy
benzodiazepine binding (51) and by solub ilization of GABA A recep tor com plexes f'rorn
mammalian brain followed by purification withbe nzodiazcpinc affin ity chromatography
(77). The cloning and seq uencing of GABAA recep tor subun its have pmvidcd evidence
for five different subunit families: a, p, "Y, ~ and p subunits . Most subunits have been
found 10 have multiple subunit isofonns : D'I-b' (3H' '1'1 .) and 111.2' T here is 30 - 40%
sequence identity among the sub unit fam ilies, whereas the amino acid sequences for
subtypes within each fami ly have 70 - 80% homology (51).
Alternative splicing of prim ary mRNA transcripts also generates subunit lsororms
called splice variants. Thu s. the 'Y2 subunit exists as '1'25 and "Y21.which tliffer by 8 11lninu
acid insertion in the intracellular loop between the transmem brane dom alns M3 and M4
(39). Bovine, ra t and human brains possess both forms of the 'I'lsubu nit as de monstrated
by immunocytochemistry . Alternative RN A splici ng of thc bovine 'Y2subun it rcsuns in
a long and short variety ofthe '1'2subunit (94). Ch icken GABAArecepto r f1~ sub unitalso
has two spl ice variants, (J~ a nd (J~' . differing in 4 am ino acids in the intracellular loop
between the M3 and M4 mem brane spanning regions (5).
The individual subunits of GADA" receptors also differ in their molecular weights
w ith Q. (J and ..,. being 48-5 3 kDa. 55-57 kDa and 48 - .so kDa, respectively. The
m olecular weight of the pur ified receptors has been found to be between 240 - 250 t Oa.
w hich if compared to the molecular weight of individual subunits is found to be
consistent with a pentameric structure (77).
Each subunit of the G ADA... receptor has a prominent Ncterminal of about 200
a mino acids in the extracellular region, considered to contain ligand bind ing sites. four
putative transmembrane dom ains (M I - M4), a sho rt extracell ular Ccterminal and a
cyt oplasmic domain of variab le lengt h between M3 and M4, which bears consensus sites
fo r phosphorylation (61). Cha racteriza[ionof GABA" receptors by using radioligands has
speciried a number of drug biooing sites on lhe receptor complex. In addition to the
ligand bind ing sites. the extracellular N-tenninal region also conta in sires for
g lycosylation.
The five protein sub units wh ich presumably fonns GAB A" receptors have a
c ircular rin g-like arrangeme nt. The individual subunits traverses (he lipid bilayer of the
neuronal membrane and toge ther forms a cylindrical narrow aqueous pore at the centre.
The ion cha nnel is lined by five M2 a -helices and each of them is contr ibuted by an
ind ividual subunit. Charged groups at either end of the pore and, the amino acid side
cha ins lining the pore , determine the ion permeability and selectivity (90) . Biochemical
studies have suggested that each GABA" receptor contains five protein subunits, but the
actual stoichiometry and the receptor subunit composition in mammalian brain is still
unknown . Information is also lacking regarding the subunits which com bines to form
functional receptors in situ.
In recombinantly expressed GABA " receptors. there is evide nce that OIl least J
different polypeptides, most commonly ex,/3y"Y, are needed to fonn <l functiunal GAHA -
benzodiezepine receptor complex (50) .
GABA" receptors arc the target for a number of pharmacologically and clinically
important drugs . Electrophysiologic al and binding studies suggest that part of the
pharmaco logical action of drugs like sedative-hypnotics. nnxiogenic. convubunts ,
antidepressants, anesthetics. anxiclyncs. anticonvulsents and ncurostcruids is lll~'t! ill\ed
through GABA...receptors (74). Man y of the drugs in the above mentioned categories do
not bind to the GADA binding site but interact indirectly with it by attac hing themselves
to allosteric sires on the rec eptor (74) . The s ite for GABA bind ing is la belled by .lgollists
such as [3HJGADA or l' Hl muscimol. Both high and low affinity sites for GA llA .md
other ago nists are present on the GABA" receptor . The low affinity she has slime
preference for GADA antagonists and ca n be labelled by spc itlc :lnlllgonists like
( + )bicuculline or SR 95531 (74). T he GABA" receptor chloride channe l can he hlocked
both by picrotoxin and penici llin. The binding of GAB A and other agon lsts to the lignnd
binding site is altered by barbiturate s, benzodiazepines and steroids (76). Pentobarbital
has been shown to increase the numb er of high affinity sires for GAB A (74). There is
a separate site for benzod iazepines where agonists like diazepam. fhrrazepam and
antagonists like flumazenil bind (9) . Heteromerlc GABA,\ receptors expr essed ill vitro
bears functional resemblances wit h the native receptors found in mammalian br ains.
suggesting the presence of hete romenc receptors in ~ivo . On the other hand, in vitro
expression of homomeric receptors has also bee n proved to produce funct ional ion-
c hannels . This is indicati ve of the presence of ligand binding sites on individual subunit.
1.2 Pharmacology of GABAA receptor subunits
Among the subunits which make up the GA DA...re ceptor, the c subunit plays a
major ro le in imparting specific phannacological character istics to the receptor complex.
S tudyo f receptor pharmacology is quiteoften expa tnedby the effec ts of pharmacological
agents in terms of its affi nity and efficacy towards specific recepto rs . Efficacy of a drug
is referred to as the maximal effect prod uced by it at the receptor. Affin ity gives a
measure of the potency of the dru g to bind with the receptor in order to produce a
particular level of response. The a subunit has been found to be the major determi nant
of efficacy for par tial GADA agonists like (RS)-d ihydromusc imol. piperidine-4-sul fonic
ac idand 4 .5.6,7-tetrahyd roisoxazo lo[5,4-c ) pyndtn-J.o!at recombinantGABA...recep tors
expressed inXenopus oocytes (19) . Again coexpression of 01 with elmer 03 or as a long
with different 13 and r subunits shows that 0 1 is mainly re sponsible forde termining the
e fficacy . whereas the affi nity is depende nt on the entire com bination of subunits. T hus,
the phnrmncotog tcat characteristics of receptors containing twodifferent a subunits arc
di fferent from those containing a single a subunit (19). Tu induce large GADA-gated
c urrents, as shown in Xenopus oocy es, the presence of at least one a subunit is essential
(75). a~ along wit h (11dem onstrat es the highest affinity fo r GADA.
C o-expre ssion o f ~ with (3: and "Y: subun its in cult ured human ,..mbryonk kidney
2 93 cell s produces GABA " receptor hav ing high biooing affinity for mascimol anti R"
15-4513 . but no t fer benz odiazepine agoners. The binding profile of this 1"Cl"CJllOr is
s imilar to oJJi 'Yl receptors. but one to olli:1: recep tors. This suggt.'su thm O'~ nnd n.,
share similar funaiooal p roperties (96) . The pre sence o f a particul ar type o f n subu nit
isoform aclUally helps to determine benzod iazepine se nsitivity 31 GADA" n.-cepCllrJI.
Benzodiazepines aCI in the brain on a spec ific cl ass of G ADA" receptors o ften termed
benzod iazep ine receptors . For the action of henzod iazepine agonisls the presence Ill' hUlh
o and l' subunits seems to be indi spensib le . The presence or the 1': subunit along with
o and (3 subu nits give s rise to a rec eptor which is flOsitivelY mrnJullllcd by
benzodi azepines (67). C e lls tra ns fectcd with 0 1 and 'Y2 subunits produce functi mlill
receptors responsive to benzodiazepines and is s imilar to that found with rec ombinant
0 1(311 : receptors . This indicates that u and l subu nits nave sites important for the action
ofbenzodiazepines (35). Thecr subu nit Iso rorm is a majo r tlctenni ning factor in funn ing
ty pe I and II benzodiaze:pine recep tors. atfJl consutues the type I receptor . whereas type
II receptors are heteroge nous. co n taining OJ. crJo r 0, subunits . Benzcdlazepinesexh ibit
h igher affinity for type I remer than type II receptors (66 ). Type I receptor selective
d rugs such as Zo lpidem and CL 218 872 have h igh affinity for type I hcnzooial cpinc
recep tors , wherea s type II receptors have much lo wer affin ity for the same drugs (9 1).
The n, subunit confers type II benzod iazepinc binding , but has lower affinity fur
zolpidem and C I 218 872 than that fou nd with type II receptors conlaining cr1 o r OJ
su bunits . sugges ting lhat as produ ces a u nique type II benzodiazepinc receptor (65) .
Type I benzodiazepine receptors are the predom inant gro up in the eN S (66). Fu ll
agonists at benzodlazepinc type I recepto rs have negligible action at (3iY2 receptors but
non-speci fic benzod iazeplne agcnists like d iazepam produce a significant pote ntiation at
the sa me rece ptor. This might be due to the fact that type I benzodtazeptnes have a
bind ing domain specific for the o . subuni t, whereas the non-selective drugs might bind
to varying sets of interacting dom ains pro vided by 132 and 1'2 subunits (35). Evi dence for
the presence o f allosteric binding sites on 0 and l' has led to the proposition of location
of alloster ic benzodiazepine bind ing site having overlapping domain on the individual
subunit prote ins (83). The efficacy of be nzodiazepines at different receptor subtypes is
found 10 be in the order otdJI1'1> 0 11'2 > {J21'1 (35) . The histidine residue at position 101
on the 011 subunit is important for the cons truction of binding domains for benzodiaze p lne
ago nists such as diazepam and zol pidem (95) .
Cerebellar granule cells possess a novel GABAA receptor hav ing subunit
comb ination OJJl1'l, conta ining a unique benzod iazepine site sensitive to antago nists and
inverse agonis rs, but insensitive to agonise such as d iazepam. Based on the
pbarmac ologjcal properties. this receptor subtype is considered different from both type
I & II hcnzod iazepine rece ptors (49). A single amino acid subst itution (A rg- lOO to
glutami ne) on the 0" subunit restores diazepam sensitiv ity, but the sensi tivity to GADA
rema ins unaltered (40).
The presence of a (1subunit also p lays an important role in detenni ning the action
of ngo nisrs at the GABAA receptors. The maximum GADA response increases when the
13~ is present instead of 131 in combinat ion with the 0 and 'Ysubunits (18), but Ihe only
exception to this is seen when Ct~ subunit is present The O.t subunit has it greater
sensitivity to GA DA than 0 1 or PI ( 18. 24), when combined with 0' 1 and 1'. , but sensitivity
is increa sed for {3~ if 'Y~ is present. The potency for GA SA was found to he in dl:'cl1.'"sing
order for the 0I102'Yl , a lPl')'J and Ctl.a:')' ~ receptor subtypes. respectively . but max imum
current elicited by GABA was found on the latter combination of receptor (IS) .
Mutational analysis suggests that amino acid residues at position 157, 160. 202 ,tllli 205
on the 13 subunit arc eSSCl, .<tt for activation of the GA DA...receptor channel by GAllA
and the activation is drastically impaired it"they are mutated. Substitution uf tyrosine "t
position 157 and 205 on the J3-subunit with phenylalanine or serine decreases sensitiv ity
to GABA and increases the EC.\lI'A greate r decrease in GADA sensitivity is found wuh
serine than with.phenylalanine substitution suggesting the necessity of aromatic rings fur
GABA mediated activation of the receptors (I ). For the action of hcnzod iuze pi nes. the
presence of 01and 'Y subunits are necessary, bUI contlicting report s have ap peared
concern ing the influence of the f1 subunit on benzodiazc plnc pharmacology (24 ,M,75) .
Anothe r important subunit of GABA" receptors is the 'rn.. which makes u
substantial contribution 10 the pharmacology of the receptor subyipc. The presencc of a
"rn. subunit in GABA...recepto rs along with a 1 and 01 gives a log-corcentnuion response
to GADA with a steeper Hill slope than that obtained with OIlfl l alone (33). Hill slope
provides a measure of the number of ligand molecules binding to the receptor. Incl usion
of Ihe 1' 21. subunit results in an increase of binding site for GAllA within the rccctor
complex, as is evident from an increase in Hill slope. The potency of GARA at the
receptor was also found to decrease with the addition of 'rn. (33). POlentiat ion 01'GAIIA-
mediated current by benzodiazepinc flunitra zepam is not found at the ad3] GABAA
receptor a nd more over a slight inhi bition of the response is noticed too (91) . This
strongly shows the potentiat ion of IGAM (GABAA receptor mediated inward ch loride
current) is dependent upon the presence of the 1'2 subunit (33 , 75). Contrary to these
studies, diazepam enhanced IGAM in Xenopus oocytes expressing only cx{3 subunits (56).
This particular benzodiezepine pharmacology is different from other obser-ations and
potcntiatio n of GADA-current is elic ited non- specifically by agonists, antagoni sts and
inverse ago nst s at the henzodiazepine site. Benzodiazepines are responsible for increased
frequency of channel opening of GABAAreceptor t...)n~~ in ing the "1'2 subunit. In contrast
to hcnzodi azepines, the effect of pentobarbital is not dependent on the 1'1 subun it (33) .
Barbiturate s on the other hand increa se the maximu m response to GADA by increasing
the mean open time of the channels.
The ligands at the henzodiazepi nesite ha ve higher efficacy at receptors containing
1'2 compa red to the "1'1subunit. Partial and full inve rse agonists for the benzodiazepine
site have been found to lose their property a nd produces slight potentiation of GABA~
curre nt at recepto rs containing the 1'] subunit a long with the cx] and (31 subunits (92) . The
1': subunit i-sknown to be responsible for benzodiazepine potentiation, but homome ric 1'2
receptors have not been found to be sensit ive to be nzodiazepines (82) . Most of the
GABAA receptor subunits fonn homooligome ric ion channels, although less effici ently
and they arc insensitive to bcnzodfazeplnes (6) . A singl e amino acid residue (thre onine-
142) on the 1'1 subunit has been found to have a key role in benzodiazepine
pharmacolog y. The antagonists and inverse ag onists at lhe benzodiazepine site behaves
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as a pan ial ag onist i f threoninc- 142 is mutated to serine. The alTinilYfor GA UAremains
unchanged In receptors containing both 'Y~L." and 1'~I..>er expressed sep arately with CY1 and
13: subunits in HEK 293 cells (53). Non-specific agontsts like diazepam, alpraznlnm or
ctcnazepam produced greater potentiation ofl o ADA in rece ptors with mutated subtype than
wildtypes and the modulation was strongly depende nt upon lhc concenrmt lcn of GAllA.
Benzodiazep ine type [ selective agcntsts . such a s zclpidcm and atpklcm pnll.luccd halt
maxi mal porenuauo n ofthc GABA response on receptors withmutated subunit, compared
to the normal subtype (53).
GABA A receptors can be modulated function ally by ptlSllra nsl;ltimml modilic;lIioli
of the receptor subunits. This is carr ied out by gtycosylmion and phosphorylation
(55 ,85). N-Iinked glycosylation (32,58.84) and ph ospho rylation (42.38,44,45 .57) p lnys
an important role in receptor regulation and thei r translational modification depends Oil
the subunit co mposition of the GASA" receptor.
1.3 Regional distribution of GABA ,\ receptor subu nits
GABA A recepto rs are widely dist ributed through out the mammalian eN S. The
presence of particular subunit isofcnns in specific brain areas has occn investigated hy
immunohistochemical, immunoprecipitation an d in-situ hybridization techniques.
Irnmunoaffinit y chro matography and northern b lot ana lysis arc also used as tool s 10
examine exp re ssion o f different recepto r subun its. These different technica l tools are
employed to determine the subunil combinat ion of receptors in particular brain reg ions.
Study of pha rm acolog ical agents on recombina n t receptors shows a variety of effects
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based upon the receptor subunit comb nauon Establishment o f receptor composition in
~pc...'i.: i lic brain areas will allow development of drug s with more select ive and target
.pccific act ion at the receptor level. Subunu specific antibodies are important research
\l)ill.~ I II isolate receptors from differem reg ions of brain, Composition of GA BA"
receptor varies in dif ferent brain regions and immunopreci pitation of these GADA"
receptors from specific hrain areas with subunit specific antibod ies has he lped to parti ally
deci pher the subunit compcs uion of the receptors . From different studies it appears that
one ur more 0: subunits, one or more {3suhunits and a l' andlor 0 subunit form functional
GABA" receptors ill vil' o. As has been predicted by many researc hers , the most co mmon
combination might be 0:1{321'2 (9). The C!:1{3('f! subtype of GAD A" receptor is found to
share Simi lar gating properties with neu ronal GABA" receptors (4 3). Elect rophysiological
studies have shown that the favoured stoichiometry for recombinant GABA" receptors
appear s to he 20:, IP .2y when 0:1. Pl and 1'2 subunits are express ed (3) ,
III situ hybridizati on and immu nohistochemical stud ies show a complicated
heterogeneity in the subunit composit ion of GABA... receptor s in the e NS, The most
abundant a subun it isoforrn found in the adult e NS is a I ' Also in situ hybridization
points III the fact that a and {j subunit RNAs are present in areas of e NS which contain
a high densit y of GABAA receptors like the hippocampu s. cerebral cortex and cerebellum
o f rat (71) . One in situ hybrid izat ion study of different GABA" receptor subunits
demon stra tes (97) co-localization of (XI and P2 with the 1'2 subunit mR NA and their
prima ry occurcncc is found in olfactory bulb, globus pallldu s, inferior colJicul us,
substantia nigra pars rcticulara , zona incerta, subthalamic nucleus, medial septum and
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cerebellum(97). The 0(1 subunit is also evenly distributed ;ICroSS many brain urcas, hm
is absent in some areas of thalamusandcerebellum. Co-localization o f 0 1 ami (3,mRNAs
can be found in areas of amygdala and hypothalamus (97). In much of the forebrain co-
distribution of o:~ and 0 subunits is found. The predominant for m of GAllA" receptor
reported in the hippocampal formation is a, fit along with the 1'1subunit (97). A wide hut
uneven disrrlbutlon can be noticed for the 0'. , and 0'.4 subunits. Primary occurcnce of fl ,
subunit is in the claustrum of basal ganglia. septum, neocortex and a low occurcncc is
seen in olfactory bulb, hippocampus. amygdala and in a few areas of Ih;II:nI\US ,lilt!
hypothalamus. A major distribution of the a. subunu is seen in hippocampus and
tha lamus (97.2). The GADA " 0; \ subunit specific antibody shows low lnmuuuucacnvuy
but is distributed across several neuronal population including cortical uacrucurons.
hippocampalCA3 pyramidal neurons. anterior thalamic reticular nucleus ami cerebellar
Purkinje cells (86) . Neocortex. hippocampus. septum. tha lamus am.! some paris of basal
ganglia shows a complex distribution of different 0: subunits.
Amongthe Bsubunit fsoto rrns. {Jl ISextensively distributed ncruss the hmiu The
highest relative specificactivity for ihe {32 subunit in rat brain is found in the hrain stem
followedby inferior co lliculus, olfactory lobe and cerebellum (50). Similar ohscrvation
has been noticed with in situ hybridization also (97). fJ3 is mainly found in olfuctory
bulb. cortex. hippocampus and cerebellum hUI occurencc of Pt is mainly found in
hippocampus and rarely in cerebellum (68,97).
The major subtype of the l' subunit is 1'2 which is present in almnst all arc;ls or
brain, but the pattern of distribution for 1'2subunit RNA does not necessarily match Ih:11
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for Q and (3subunits (67,71). Distribution of "(I and ""1') is fairly restricted in the brain and
80-90% of e NS neurons contain the ""1'2 subunit. The primary localization of "(2 is
observed in the mitral cell laye r of olfactory bulb. pyriform cortex, parts of neocortex ,
hippocampus. cerebellar purkinje cells and in some parts of hypothalamus. septum and
amygdala (97). Assessment of the distribution pattern of both forms of ""1'1 subunit. "(2S
and "(21. shows the abundance of latter in layer II of striate cortex and cerebellar Purkinje
cells. superior and inferior confcutus, deep cerebellar nuclei, medulla and pons. The
regions enriched in "(2S are mitral cells of olfactory bulb. pyramidal neurons of pyriform
cortex. layer VI of the neocortex. granule cells of dentate gyrus and pyramidal cells of
the hippocampus (22,51!-). Cerebellar granule cells and some other cortical structures
express both "( IS and "(2l in comparable amounts (54) . The subunit composition governs
the GABAA receptor phar macology and difference in regional assembly of GABAA
rec eptor has some important implications towards it.
1.4 Effect of propofol
Propofol (di-isopropyl phenol) is a potent intravenous anesthetic agent which is
chemically unrelated to barbiturates, steroids, imidazole or eugenol agents and is suitable
for both inducing and maintaining anesthesia (36). Propofol is well known for its use in
the induction of anesthesia in outpatients undergoing ambulatory surgical procedures
requiring rapid onset of action, stable operating conditions and rapid recovery from
anesthet ic effects on cognitive and psychomotor functions (79.41). With propeful, the
plasma concentration for sedation is 0.5 • 1.5 JIg/mI. while 2 - 6 Jlg/ml produces
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hypnosis (79). A highly lipophilic dru g. propofol, has a fast onset of action due til ",p id
penetration through the blood-brain barrier (37) . At both subanesthctic and anesthetic
dosages, propofo l evenly di stributes itself throughout the e NS without any regimml
prefere nces (73). Accumulation of propofol is found in bra in which ts evident from the
observation that the co ncentration of the drug in rat brain line r nn ccn nuraucs (If
propofol infusion is 15. 7 ± 1.9 Ilg /g which is 3.5 and 8.5 limes the dru g conccntrarion
in whole blood and plasma respectively (73). It is known to IlCa short ,Icting nncsueuc
because following drug administration the concentration of prup olul in phlSIllOl declines
rapidly, as it redistributes itself from brain and other highly perfused tissues In Ics.~ well-
perfuse d tissue sites (37.79) .
Two major theories have bee n advanced to exp lain the effec ts of anesthetic agents.
It is believed that anesthetics interact with the macromolec ular structure o r the neuronal
membrane by chang ing phys ical propert ies such as fluidity. This sUl~esl ion is mainly
based on the correlation between the anesthetic potency aml lipophilicity of the drug (RK).
The change in the lipid property is assumed to affect protein structures embedded in the
matrix of the cell membrane . The other theory is based on the hyptlthesis of ancxthctlc-
protein interaction . Anesthetic agents seems 10 have speci fic binding sites on rec eptor
protein subun its in the eNS and the interaction causes a contormauonat change in the
receptor structure which leads to alt ered funct ional properties (88) .
GABAA receptor s, which mediate inhibltcry transmission in the eNS. arc believed
to be a primary site of act ion of anesthetic agents irrespective of their che mical structures
(47.98) . General anesthetics have been shown to modify GAR A", receptor med iated
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responses (47). A strong corre lation exists between the hydrophobicity and anesthetic
potency of the chemical compounds (98). However, this may be due to the presence of
hydrophobic binding sites on the protein subunits of the receptor. There are probably
different ways by which anesthetics mediate their effects through GABAA receptors . This
might involve alteration in agonist binding. receptor-channel coupling or a d irect
modulation of channel gating (60).
Propofclap pears also to interact with GABAA receptors. tn in vitro studies with
rats. propnfol has been found to produce a brief dose-dependent inhibition of pars
renculau neurons of substantia nigra which are known to be inhibited by GADA-mimetic
drugs and henzodiazepines (62) . The inhibitory effect on pars reticulata neurons was
potentiated by diazepam and reversed by picrotoxin and blcuculline and not by the
bcnzodiazepinc antagonist Ro 15-1788. thus suggesting that propofol has a GA DA·
mimetic action. Again. in rat olfactory cortex slices. clinically relevant concentrations
of propofot potentiate GADA-mediated transmission (12) . The same phenomenon was
observed on mouse hippocampal neurons (60). where 2·100 ~M of the drug potent iated
GADA-activated responses and reduced receptor desensitization. A concentration of 10-
1000 ~M propofol directly activated and desensitized the receptors, whereas 600-10000
~M propofol produced a non-competitive inhibition of GABAA receptor responses (60).
The effect shown by lower co ncentrations (2-100 JlM) of propofoJ probably has some
pharmacological significance, as the arterial concentrat ion of propofol for loss of
consciousness has been found to be between 16.8-22.4 /-1 M (30). Propofol has also been
observed to shift the GABA dose-response curve to the left. from mouse hippocampal
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neurons, without changing the ma ximum response (60).
Desensiti zation o f GABA" receptor s depends upon the co ncent ration Ill"GAllA .
but at the same tim e it is dependent on other ligands at the receptor site which can Cl1lSS·
desensitize the receptor (60) . Cross-desensitization of GABA-mediated responseswith
propofo! is likel y, as it ha s been observed Ihal preincubation with GABA reduces the
effect of suhsequent propo fol applica tion (28) . Redu ction in the rille of dcscnsil iz:ltiull of
GABA response s with low propofol concentrat ions has hccn suggested to he due 10 an
alloste ric intera ct ion at th e GASA" recept ors (60 ) .
Single channel studies of GABA /\. recep tors have reveale d uuu prtlpnfnl
potent iat ion of GAS A responses results mainly from an increase in ch<l1111c1 opc ning
freque ncy and pro babilit y and not due to Increase in channel open time or single channel
conductance (60). However , a prop ofol-induc cd increase in chloride con ductance has also
been repo rted (26 ).
The ro le of propofol to influence binding character istics of other drugs to
GABA...receptors in rat cerebral co rtex has also been extensively reviewed (62). Propofll!
was fou nd to e nhance GA DA bindi ng in cor tical mem brane preparati ons lU\ll p otenrimc
muscimo l-induced stimulation of Cr uptake in memb rane vcscicle prep aration. The drug
also inh ibits t-butylblcyc lophospbo romlonatc (TBPS) binding to unw ashed rat cortica l
membra nes (15 ,62) and it fails to di splace flunhrazepam from its bindi ng slte , ind icating
that the bindin g site for propofol is different from that of the benzodiazcpincs.
Concom itant application of propofol either with alphaxalonc or pentobarhinme nil rut
cerebra l conex membran e produ ced an addit ive inhibition of TBPS binding which
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provides evidence for separate sites of action of these drugs (15,13), Evidence from
drug-binding studies strongly sugges ts that facili tation of GABA" receptor function might
have releva nce .;fl mediating the anesthetic effect of propofol.
The subunit specifici ty for action of differe nt anesthetics is not very clear, but
recently it has been noticed that the presence of fl subunit is probably necessary for the
posit ive modulation of the GABA/\ receptors by non-vola tile anes thetics (31). A recent
report has shown that the ac tion of the general anesthetics pentobarbita l and propofo l is
subunit specific (70). In Ihat study . propofol directly activated 0I.131'YZS' 0/1131 and 131'Y2S
GADA" receptor subtypes but not OI(),ZS showing that the presence of the IJ subunit is
required for di rect activation of GA BA" receptors by the anesthet ic (70) . The homomeric
{il receptor, which is completely insensitive to bicuculline, showed pronounce d direct
activation with pro pofol and pentobar bital (70) . However , elpbexalone (steroid anesthetic)
d id not directly activa te 131 homomeri c receptors, although it co uld potent iate the effects
ofGABA.
Applicat ion of propo fol to bovine chromaffi n cells and rat cor tical neurons
produces a dose- dependent potent iation of the inward GABA current which is not
influenced by the benzodiazepine antagonist tlumazenil. This suggests a separate site of
action for propofol and benzod iazepines (27). Diazepam but not pentobarbital has also
been reported to enhance prupofol -tnduced current on rat hippoca mpal pyramidal
neurons, amI this effect is not blocked by R0l5-1788 (30) . Propofol is increasingly used
in clinica l practice and benzodiazepioes are often used in conjunction with propofol ,
either as a pre-anesthetic medication to reduce anxiety or as an adjunct for the induction
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of anesthesia. In clinical cases propofol has been reported to show synergism with
midazolam. a beruodiazepinc agonist. though the nature or intcracuc n :II the level of
GADA...receptor is not known (72.10) .
I. S Clinica l effects of benzodiazepines
The class of chemical compounds classified as imidazobcnznpyndin c derivatives
and sharing a common phannaeological property of sedation and hypnosis arc known ,IS
benzodiazepines. Drugs included within this category are Il urazepnm, diazcp.nu.
triazolam, flunitrazepam. remazepam and many others. Flurazepam was the first umong
all benzodiazepines to be marketed selectively as a hypnotic agent (34). All
benzodiazepines are lipophilic substances though they vary in their quantitative
lipophilicity (20). Diazepam is one of the most lipid soluble substance while lorazepmn
has less lipid solubility (20). In brain the effects of bcnzodiazcpines arc mediated through
a specific interaction with GADA...receptors sensitive to these chemical CtJlllj"K)(;O!JS and
are widely d istributed on post-synaptic neurons within the CNS (25). BCI17.uJill7.Cpines
cause a positive modulation ofGABA·induced inward CI-current (20). The clinical effect
is determined primarily by the dose administered (and thus the degree of receptor
occupancy) rather than the panicu lar benzodiazepine (20). All benzodiazepinc agonists
produce a concentration dependent sedation, drowsiness. performance and memory
impainnent, amnesia, ataxia, antianxiety and anticonvulsant effects (34). Tile dosage uf
differen t benzodiazepines varies depending upon their potency. The major uses or
bcnzodiazepines are for the treatment of anxiety states and sleep disorders. However.
19
they arc also increasingly used as a pre-anesthetic medication in conjunction with other
anesthetic agents. The affinities of different benzodiazepines for GADA" receptors differs
significantly. Like other phann acological agents, bcnzodiazepines also cause unwanted
side effects like eNS depression including drowsiness, dizziness, fatigue. light-
headcdncss and incoordination. All of these probably represents extension of their
pharmacological action (69) .
1.6 Merit s or th e Xenopus oocyte expression system
The Xenopus oocyte expression system has evolved to be an important and
powerful research tool for studying functional properties of cell surface receptors
following the translation of exogenous mRNA (80). Oocyres have proven repeatedly to
be an efficient in vitro system for accurately translating foreign receptor mRNAs,
processing the product and effectively inserting it into the oocyte membrane (89).
Xenopus oocytes are capable of performing a number of post-translational modifications
to receptor subunits including glycosylation. phosphorylation and subunit assembly.
However , not all the modificat ionsare always seen with all exogenous polypeptides (82),
which suggests the possibility that oocytes might be incapable of recognizing all
exogenous signals for post translational modification. Transmitter receptors expressed in
oocyres display certain properties not found in uninjected oocyres showing that the
phenomenon of expressing the brain receptors is dependent on exogenous sources. In
oocyres. the Si7£ of a particular response mediated by a receptor varies and is probably
proporucnat 10 the amount of injected mRNA coding for the specific receptor (93) .
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Func tional amino acid receptors (G ADA, glycine , NMDA and kalnutc) arc expressed in
Xenopus oocytes upon injection of rat brain mRNA showing thc capacit y Ill' oocyrcs tu
synthesize and assemble a variety of synaptic neurorransrrnncr receptor s (RI) . GAB A
rece ptors synthesized in-vitropossess similar pharrnncotoglcat ilnd gating properties as
found with GADA" subtypes present in the CNS . They have similar binding sites I'm
benzodiezepl nes. barb iturates, picrotoxin, bicuculline lind other ligands (78 ,34) ,
Significant metabolic differences are found between oocyrcs from different sl:lges
(I-VI). The stages of oocyte can have a profound effect on translation of iltiectcu
message s and processing of proteins (80). Components required for protei n synthesis
during ear ly embry ogene sis are found in full gro wn oocytes (stage VI) in large reserves .
The ability to synthesize proteins varie s between different stages of oocyrcs. the
maximum being found in stage VI oocytes. Orner than the difference in eapnchy In
synthesize proteins. differenc e also lies in sizes between various stages til"oocytcs. Stage
V cocytes have a diame ter of 1000 ~ 1200 pM whereas stage VI oocyrcs have diameter
larger than 1200 ~M (80).
Oocytes extracted from frogs do not have endogenou s GADA" receptors, hUIthey
act as a very good exp ression system for the rece ptor pro teins formed Irom the rnrcillll
DNA introduced , by subsequent steps of transcriptio n and tra nslation. Ideally , molecu lar ,
electrcphysiological and pharmacological characterizatio n of a specific ion channel
demands its express ion in a defin ed memb rane en vironment where interaction with lIny
other neurotransmi tter receptor is absent. Injection of cloned DNA/ RNA for pankular
recept or subunits in cocyte s produces receptors and this can he parti cular ly useful for
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phann acolog ical characterization of any receptor combination believed to be present in
the eNS. Untk rstanding the molecular remre of synaptic communication is greatly
faci litated by these gene probes which encode a host of ion channels and receptors . These
prohes penn it a critical characterization of the structure and function of receptors
following expression in Xenopus oocyres (81).
A varicty of ligand gated ion channels which can be efficiently expressed in
oocyte system includc GABAA , N-Illelhyl d-aspan atc (NMDA), serotonin (S-UT) and
acetylcholine receptors. xenonusoocyres perform as a sur rogate system for ion channel
expression and the receptors so formed after nanogram injection of poly(AV RNA can
be succcsnnty characterized with etecrrophystoioglcat measurements. Electrc physlologlcaI
reco rding of ligand-gated ion channels expressed in Xenopus oocyres is a sophisticated
and widely used technique for exam ining the pharmacclegical properties of these
prote ins. Ele<:trophysiological assay can detect expression of functional receptors after
an incubation period of 8-36 hours (81) . Sl.andardelectrophysiologieal technique includes
the use of two micro-electrode voltage clamp for wholc cell recordings . Recording from
oocy res has some prominent advantages over neuronal cells. Primarily. the oocytes are
much larger in size compared to single neuronal cells which simplifies the wholc ce ll
n:co rding and il is also relatively simple to introduce cDNAs or mRNA encod ing specific
n..ce pror subunits. This permits experiment designed to test the role of specific subunits
in imparting the pharmacological properties of the receptors expressed . Second ly, stable .
long-lasting (up to several hours) record ings can be obtained, allowing the co llection of
quantitative as well as qualitative data . The only question that might arise is regarding
22
the authenticity of expression of all subunit messages injected. Presently. it is not
possible to determine whether a homogeneous population of receptors are expressed or
if receptor subtypes are formed with diffe rent composition and stoichiometry .
1.7 Rationale and objective
Propofol is a widely used short act ing. intravenous aucsthcrlc agcrn which has
been found to have an effect on GADA" receptors. Little lnfo rmatlon is llvllil;,hlc
regarding the subuni t dependence of propofol with regard to moduillting GAllA" receptor
function. There are a few repon s (31.70) which mentioned the importance of the (:J
subunit for propofol 's action on the GADA" receptor. It has also heen observed thon
without the presence of the {3 subunit propofol fails to directly activate thc GAllA"
receptor chloride channel. The majorit y of the work with propofol with respect to ils
affinity or efficacy has been done on neuronal cells where the subtype of recep tors
present is not clearly known. Propofcl also has effects on other neurotransmitter
receptors and ion channels. It is 110t known if other neurotransmfncr receptors that can
be modulated by propofol have some effect on the specificity or proporot 's action on
GADA" receptor in neurons. Considering from that perspective, use of oocyte expression
system is preferred where no other receptors are present except for the ones expressed
as intended . There has been no report yet where the efficacy and affinity of propofo!
have been studied on a defined population of GADA" receptors. Efficacy or uther
anesthetic agents such as enflurane has been observed to change with changes in suhunil
composit ion of GADA" receptors. I propose to lest the hypothesis that change in xubumt
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cornposhio n of GADA" receptor will alter the effICacy andlor affinity for propofol.
Benzodiazcpines are often ccmbire d with propofol as preaoeseetlc medicalions
enbe r to reduce preoperative stress or to enhance anesthesia. Attording 00clinical reports
(72. 10). a combination of the bereonazep tre . mklazolam, with propafol acts
syncrgi<;;tically for the induct ion of anesthes ia. Temazepam was similarly found to
alleviate anxiety and significamly increase the cognitive recovery time for patients
anesthetized with propofol and alfentanil (4 ). All reports of synergism between propofol
and bcnzod tazcplnes come from cl inical trials. There is no direct evidence of an
mrcracno n at a common receptor. though there are suggestions that the effect might be
mediated through GADA" receptors. I propose to test the hypothesis that there is II
significant interaction between the two classes of drugs at GADA" receptors and that
other chemical classes such as cyciopyrrolones which act at or near the benzod iazepine
site can also participate in this type of interaction.
To investigate the above hypothesis. 1have chosen to em ploy theXenopus oocyte
express ion system. Theoocyte system can express functional brain receptors , as evide nt
from other research works. All effectsof propo fol which are found in mammalian cells
should therefore be replicated in this mode l system.
The objectives of thill study were 10 examine:
the effect of propofo! on GADA-activated responses at Q lI3Z"YI L and Q 213a l L
subtypes of human GADA" receptors:
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ii) if propofol and benzod iazepines aCI synerg istically at tile GAllA" receptor and if
so, whether M the same site on the GARA" receptor :
iii) Ihe nature of the mreracnon of propofol with zoplcrone, a cyc1\I\lyrru!tlne
deri vative known to be a full agonist lit the hcnzodiazcpine sile (111 the GABA...
recepto r
iv) the role of the 1'2Lsubunit in potentiatin g GA RA" receptor function wilh Ilrupllfll l :
v) whether propofol does have any ef fect 011 the dcscnsuizarion of the GAIIA-
med iated receptor responses.
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2.11 Methods
2.1 Purifl caflon ofC.;ABAi\. receptor su bunit cDNAs by th e method of Alk ali Lysis
2.1.1 Tran stcctton of se lective micro-o rganism with eDNA
Subunits o f the human GABA~ receptor were received as an ethanol precipitate
(Merck Sharp & Dohme Research Lab}. Each eDNA was dissolved in TE to a fina l
conc cnmulon of 1 ~1l/~L. A I loll aliquot of each eDNA stock was then taken into a
micro-centrifuge tube and TE was added 10 a final volume of 200 J(L, so as to make a
final co ncentration of 5 ng/~L. The cells (E. Coli receiving the transfection
(MC I06 11P3; Invitrogen Corp.) were kept frozen unti l used. 50-100 ItL of the cell stock
W'I.~ then taken in a micro-centrifuge tube and combined with 5-10ItL of 5 ng/ltL eDNA
stocks fo r each subunit. Th e volume of eDNA was always kep t less than oreq ua l to 10%
of the:ce ll volume . The tubes were put on ice for 20430 minutes followed by heat shock
,It 42"C for SOseconds. Immediately after the heat shock LB (prewanned to 37"<:)was
adued to each tuhc to a final volume of 1 mL. The rubes were shaken for 45 minutes at
:I temperature of 3'''C in a horizontal position to allow proper aeration and the eDNA 10
he taken up.
After shak ing the suspensions were spun down al6000 rpm for 10 seconds. The
supematarus Were discarded and the pellets were re -suspended in 100 pL of LB. The
micro-organfsms were the n plated on agar { 1.5% Bacto-Agar in liquid broth) with
antibiotics (tetracycl ine - 7.5 IAg/mL : ampicillin 4 25 JLg/mL) . Cells were plated with 2
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,J.L, 10 ~L and 88 III o!" the cell suspension per plate . The plates were ineuh,ilcd
overn ight at 37"C.
2.1.2 Maxi plasmid prepar ation by alkali lysis
Day 1:
Two litre flask s containing 500 mL 1.8 with untibimics were prepared fllr
indi vidual subunits. A wire loop was flamed . cooled and a single bacterial colony wus
pic ked up by gentle touch and transferred 10 a flask. The innoculates were placed {lit u
shaker overn ight at 37"C.
Day 2:
Aner 17-18 ho urs of incubation , the cultures were transfer red to pre-cooled 25U
mL centrifuge buckets, and incubated on icc for 10- 20 minutes. The cells were spun
down at 4000 rpm for 10 minutes . The supernatant was dra ined off and the inside of each
individual bucket was wiped carefully to remove excess medium. The pellel Inun each
bucket was suspended in 6.5 O1L of Solution 1 aOO transfercd In a 50 lUI. Oakridge tube.
The tubes were allow ed to stand at room temperature for 5 minutes. Thirteen lll~ or
freshly prepared Solution 2 was then added to each of the tuhes and mixed gent ly, hUI
thoroughly. to ensure comple te lysis of cells. They were placed on icc for another 5
minutes and then 6.5 ml, of ice cold Solution 3 was added. At this stage protein and
chromosoma l DNA precipitated out. The tubes were again placed on ice for anomer 10
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minutes . The precipitated DNAs were then spun do wn at 12000 rpm for 30 m inutes. The
supernata nts were poured separately into fresh 50 mL Oakri dge tubes and precipit ated
with 15 mL of iso-propanol. The y were mixed Ihor oughly and allowed 10 stand at room
temperature for .5 minutes. At this stage Ihe plasm id DNA precipitated and was spun
down at 8000 rpm for 10 minute s. The supernata nts were d isca rded and the pellets were
allowed 10 dry for a coup le of minutes by inverting Ihe tube . Each 500 mL culture fro m
a single flask was divided into IWo 250 mL aliquots and each a liquot was carried thro ugh
the isolation proced ure separately . At th is stage the two pellets were pooled together in
3.0 mL ofTE buffer and transfered to a 15 mL Cor ex rube. The pH for individual tubes
was checked 10 ensure tha t it wa s neutra l 10 slightly alkaline ( adjust ed with NaOH if
necessary) and the volum e was made up to exa ctly 4.2 m L. 30 ~L of RNAase A
(I0 mg/mL) was added to each tube.
To each of the tubes 4.7 g CsC] and 500 ~L ofe thidium bromide (1Omg/mL ) was
added and dissolved comp letely. The content of each tube was spun dow n at 8000 rpm
for 10 minutes to separate any precipitate. if present. The clear supernatant from the
Corexlubes was transferee to separat e Ouickseal tubes with a 5 cc syringe and 16 gauge
needle. The tubes were heal sealed and checked for leaks by wi ping on paper towel while
applying gentle pressure . The tubes were put in a vertical VT i 65 rotor and spun in a
Bec kmann ultra-centrifugeat 45000 RPM at 20"C for 18 - 20 hours.
Day 3:
The lubes were rem oved carefu lly from the rotor and kepi in the vertica l positio n
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so the plasmid band remained stable . The pla smid DN A hand was so metimes vi sihlc in
ordinary light , but was easily visualized as a fluorescent band unde r long wavelength UV
light. Each tube was punctu red w ith a syr inge needle (26 ga uge) and alec syringe
needle was carefully inserted just bel ow the plasmid band viewed with long wave length
UV light . The bands were carefully and very slowly withdrawn and pl aced into 15mL
poly-pro pylene rubes. The volume of plasmid DNA obtained varied from 0.5 • I lilt.
The volume of the plasmids was mad e up 10 2 mLwith TE buffer. 11. 11 the samp les were
repeatedly treated with n-b utanol 10 extract all traces of cnudiuru brom ldc. The samples
were placed in a dessicator under vacuum for 5-10 minutes to gel rid of the excess
butanol. The aqueous ph ase was extracted twice with an eq ual volume of
phenol:chloroforrn :iso-amyl alcoho l (25:24: I) mixtur e followed by a single extraction
with an equal volume of H20 sa turated c hlorofo rm . Afte r the fina l extraction the
plasmids were trans fered to 15 mL Corex lube s. For precipitating thc D NAs, 0. 1 volume
of 3M sodium acet ate (pH 5.2) w as added to each tube foll owed by two VOIUlllL':' Ill'
100%ethanol. The tubes we re vortexed mildl y, covered with parafllm a nd kept overnight
at ·20"C.
Day 4:
The precip itated D NAs we re spun down at 15000 rpm for 30 minutes. The
supernatant was rem oved from each of the tubes and the pellet was wa shed with roughly
5 mL of 70 % ethanol ke pt at ·2O"C, The tubes were dri ed unde r Vac uum for
approximately 20 M 30 minutes. O nce the pelle ts were dried , the y were dissolved in 0.5
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mL TE buffer. Approximate concentration for the plasmid DNA was checked by
determining the absorbance at 260 nm in a spectrophotometer. Double stranded DNA
givesan optical de nsity read ing of 1 per 50 ~g/mL. The dilution factor for the plasmids
was 1:500 . Yield ranged fro m 800 - 1600 ~g of plasmid DNA fro m a 500 mL culture.
The purity of the plasmids was c hecked by running them on a 1% agarose mini-
submarine gel, the procedure for which is g iven below .
2.2 Gel Electro phoresis
Agarose powder was combined with 1X rDE buffer to make a I % solution and
microwaved until dissolved . Ethidium bromide 00 mglmL) was added ( 3.3 IlU50 roL)
10 thc luke wann so lution.
A comb was aligned for the formation of parallel wells in a clean plastic cast.
The agarose gel was poured slowly into the cast, allowed to polymerize for 20 - 30
rr unorcs. and covered with a thin la yer of IX TBE to avoid drying. After addition of
T BE, the comb was removed aJlllthe remaining TBE drained off. Marker and samples
in volumes of IO~L were ca refully added to the wells. The compos ition of marker and
sa mples arc given below:
M arker
I Kb Ladder • 1 ~L (Gibeo )
l OX loading buffer , I ilL
dHlO • 8 ILL( Diet hyl pyrocarbonate IDEPC] treated water for RNA)
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~
Sample - I ~L
lOX loading buffer . I ~L
dH10 - 8 ltL (DEPC water for RNA)
The gel was run at 100 V for 20 - 30 minutes depending upon the size Ill' the
plasmid. In some cases plasmid DNA was linearized with appropriate restriction enzymes
prior to gel electrophoresis. This gives a more accurate estimation of the size uf the
plasmid DNA obtained.
2.3 Preparation of eRNA from eDNA by ill-vitro transcription
2.3.1 Linearization of plasmid DNA
5 - 10 lt L of cDNA ( approximately 2/lg/p L) was taken in a micro-centrifuge
tube and added to 1.5 - 2 .0 IlL of lOX incubation buffer, supplied with the rcsrrictton
enzyme . Incubation buffer was used in which the restriction enzyme for linearizat ion has
100% activity . dH10 was added to make up the volume so that thc ccoccmrunen nf the
buffer in the final mix was IX. Usually I IJL of the respective restri ction enzyme (10
UfltL) was added to linearize the transcription vector containing the gene of interest. I
unit of enzyme is known to digest l /lg of cDNA at proper temperature and in proper
buffer. The volume of enzyme was always kept less than or equal 10 1<1 % of thc filml
volume . It was then incubated for at least 2 hou rs and sometimes ove rnight at 37"C.
After linearization the volume was made to 50jtL with dH10 . The reaction mix was then
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extracted once with an equal volume of pbenol-chlorofcrm-lsoamyl alcohol mixture and
once with chloroform separately. The linearized piasmids were then precipitated with
ethanol and sodium acetate as described in the maxi plasmid preparation for preparing
the cDNAs. Finally the pellet was resuspended inS - l OJIL of TE to get the approximate
concentration of the plasmid as \ p.glp.L . In some cases the restriction enzymes used gave
blunt ends or overhangs. either 3' or 5 ' . For restrict ion enzymes giving 3' overhangs,
an additional step of filling up the 3' overhang with T4 DNA polymerase was followed
to give blunt ends. otherwise it would lead to improper transcription .
2.3 .2 "'iiling up or3' overhang with T4 DNA Polymer ase
5 ilL of eDNA was taken and added to 5 ilL lOX T4 DNA polymerase buffer,
39.5 p.L dH10 and 0.5 JlL 1 4 polymerase. The mixture was kept at room temperature
for 2 minutes. To it was added 2JlL of the deoxy nucleotides (2 mM dNTP·s). The entire
mixture was incubated for 15 minutes at 37OC. It was extracted with phenol-chloroform.
chlorofonn and precipitated with ethanol as described above. Finally the plasmid was
dissolved in 10 ilL of TE. Restriction enzyme Pst I used for linearization of human 0:'2
eDNA gave 3' overhang and was filled in with T4 polymerase.
2.3 .3 In-vitro cold tr anscription
After the plasmids were linearized, the following reagents were added in order.
10 separate micro-centrifuge tubes for separate plasmids at room temperature.
iO ilL 5X TB
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2.5 ilL BSA 2mg/mL
5.0 ilL dithiothreitol (100 roM)
l.°ItL RNAsin (40UlItL)
8.0 1tL rNTPmix
2.5 ilL 7-methyl GTP cap (5 mM)
5.0 ilL rGTP (0.5 m M)
12.51tL DEPCHP
3.0 ILL linearized plasmid DNA (1-3 ItS)
0.5 ilL bacteriophage 1i polymerase
The transcription mix was incubated for I hour at 37"C. 50 p.L DNAase buffer
and I p.L of RNAase free DNAase was the n added to thc mixt ure lind further irk:uhaled
for another 20 minutes at 37"C. Afte r incubation. the entire mixture wa s extrac ted once
with phenolfch loroform and chloroform respectively . Next the cRNA so formed Imm
transcription was precipitated with e thanol at -20"e for at least 2 hours or uvernight using
potassium acetate (3M pH 4.8) . The tube was then centrifuged fur 10 minutes ut 12000
rpm for the RNA to precip itate and the pellet was care fully washed tw ice with!;old70 %
ethanol. The RNA pellet was allowed to dry under vacuum and based on tile yield was
resuspended in 10-20 ilL DEPC treated water. The concentration of RN A was es timated
by checking the absorbance 311260 nm in a spectra-photometer . The yielrJ was usuauy
between 8-25J.Lg of eRNA .
In-vitro transcription was also carried out with RiboMAX™ Large SCf,le RNA
Production System, 17 (Pr omega Corpo ration), which gave a fairly h igh yield of RNA ,
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2 .4 Surgical removal of oocytes and de -folliculation
Occyies from female Xenopus faevis frogs (Xenopus. Inc.• Ann Arbor, Mt) were
removed by surgica l procedures. Frogs were individua llyhoused in sepa rate plastic shoe
box cages contain ing filtered tap wa ter. The room was maintained at a temperature of
22 ''C with a 12hou r alternate light and dark cycle. The frogs were fed 2·3 times a week
w ith a co mmercially availab le frog food (Nasco. Fo rt Atkinson. WI). On the day of
su rgery individual frogs were brought into the laborat ory and were a nesthetized before
the operation. To anesthetize them , they were transferred sepa rately into small boxes
contai ning 500 ml of icc-co ld filtered tap wa ter containing0 .2·0.25% 3-aminobcnzoic
aci d ethyl ester (met hanesultonate sa lt ; Sigma Chemica l Co.) . After so me time the frogs
we re tested for consciousness by lightl y pinc hing the ir limbs . Anesthetized frogs were
placed on their hacks on a bed of crushe d ice and the abdomen wiped w ith 70% ethanol.
Before the operation all the surgical instruments were also wiped with 70% e thanol. A
sma ll incision (I - 1.5 em) was made in the abdomen below the diaphragm and above the
junction of tIK: hindlegs. e ither righ t or le ft of the midline with a surgical scalpel.
Scissors were sometimes used to c ut the muscular layer to avoid damaging internal
organs. Two (0 three ovaria n sacs co ntaining 200·300 oocytes were removed through the
incision wi th the help of a blunt fo rcep and cut at their po int of jun ction, so as to
mini mise bleeding . The oocyres we re transferred to a Petr i dish con taining storage
so lution (composition menti oned in Appendix I).
Once the oocyres were rem oved, the incision was stitched with sterile,
nonnb surbahlc. surgical silk suture (Joh nson & Johnson Medica l Products) . The muscular
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layer and the skinwere stitched separate ly. After closing the Incision.the area was wlpcd
again with EtOH and the frog was then traruferedm a smallplastic shoe box conlaining
500 m L of filtered tap water with 5 mL penicillin-streptomycin ( penicillin G sodium -
10000 UfmL & streptomycin sulfate - 10 mg/ml.; GihcoI)RL). Atkr the Img regained
consciousness. anadditional 500 ml, of water was added 10 the pool. The frog was then
kept in the laboratory for an additional 3 days for post-opemtlvc ohscrvarhm. WOller ill
the boxes was changed daily and fres h antib iotics were added. This procedure was
followed for threedays . If afterwards the frog had no compl ication, il was rcnma..'t1to
the Ani mal Care facility. Consecutivesurgeries ou the samefrog were done on alternate
sides of the body with intervals of at least four weeks.
The thecal. epithelial and follicular layers of the oocyte were manually removed
using fine forceps (Dumont #5). Stage V-V I oocytcs were UM:d for injection and
electrop hysiological recording. Insome casesfrogs were injected with 50 U gnlUuJotwpin
from pregnant mares' serum(S igmaChe mical Co.). Once the oocyrcs were peeled. they
were kept in 1.5% agar coated Petri d ishes with storage solution. The peeled III"ICyles
were kept overnight at room temperatu re (20 - 22"C)and only the healthy oocyrcs were
selected for injection on the next day
2.5 Micro-injection of oocytcs
After preparation of the individual cRNA for each GABA...receptor subunit, they
were mixed together in different comb inations of adJlYll.• alJall.• allz with a final
concentration of 0.8 - I ng/nL foreach subunit. They were stored al a temperature of •
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70"C and just before injection the tubes were thawed on icc. The tubes were warmed up
at a temperatu re of 70''C in a thermal cy cle {Techne, Model PHC-2) for three minutes
and qu ickly stuck in a bed of crus hed ice . Capillary glass mhes (3.5" Drummond# 3-00-
203 G/X ; Drummond Scientific Company) were pulled on an electrode pulle r (Narishige
Co. Ltd., Model PB-7) with single heater and full weight setting to get glass needles with
very fine tips. The glass needles were filled with DEPC treated water and bevelled on
a grinder (Narishige Co . Ud.• Model EG-40j.
For injection a bevelled glass needle was filled with light mineral oil (Sigma
Chem ical Co ., M-3516) and mounted in the micro-injector (Drummond "Nanoiect'
Automatic Injector; Drummond Scientific Company). A drop of the cRNA was placed
on a glass cover slip and 3-5 ~L of the cRNA was drawn in the injectio n needle .
Dcfollicu tated oocytes were placed in an injection chamber (a Petri d ish fitted with nylon
grid of a size sufficient co fit a single matur e oocyte in one square) submerged in oocyte
storage solution and the oocytes injected in the vegetal pole with the volume for iltiection
varying between !()..50 nt, Aflcr all the oocyres were injected. they were trans fered to
agar-coated Petri dishes containing storage solution at room temperature.
2.6 Eledrophysiological recording from oocytes
After 1-2 days of incubation following cRNA injection. the oocy tes usually
expressed GABAA receptors and thus we re ready for electrophysiological recording. For
recordi ng, an oocyte was placed in a nylon grid ( 1.5 mm x 1.5 mm) glued to the glass
bouom of a flow chamber (Warner Instruments Inc. , 8 rom well size) and con tinuous ly
36
perfused with recording solution (storage so lution devoid of sodium bicarbonare, pyr uvic
acid, caffe ine/theophylline and amibicncs) at the rare of 6·S mUmi n. The ooc yte was
complete ly submerged. Two-electrode voltage clamp rec urding with an Oocyte Clamp
(Model# OC-725B; Warner Instrument Corp .) at -70 mV wascarried nut using c1eetmdes
filled with 3M KCI. The elect rodes were pull ed on Nartshige electrode puller (P R.?) ;lud
glass capillary tubes of diameter 1.2 mm (Gla ss IBOL W/FIL 1.2 mill, Itell1# I B I 2nF-~:
World Pr ecision Instruments. Inc.) were used for the purpose. The oocyte was impaled
with both the electrodes using micro- manipulators. Control (recording) solution wnsUllt
turned on until the resting membrane potent ial inc reased and auainl.'dII steady level.
Ph armacological character ization o f the receptors was tlonc with a va riety of
phannacol ogically active chemical substances which were applied oran the oocyte
membran e in the perfusion chamber after dissolving them in the recording solution.
Application of solutions was controlled by a se ries of manually operated valvesconnected
to the infl ow of the recording chamber. C urrents activated by GADA. or GAIJA plus
drugs, were recorded on a strip chart reco rder (Co le Parmer. Modell 1202-()(JOO).
Immediately after application of the drugs for a period of 15·60 seconds. the oocyte was
washed thoroughly for a periodof 5- 15 minut es with IhI:control solution befor e the ne x t
application of drug (s). The control response to GABA was c hecked pcriodicutty during
the reco rd ing to determine if the response changed over time and 10 e nsure the
reversibility of all drug effects. Fo r experime nts on desensitization of GAIJA" receptors .
curr ents ge nerated by application of 250 ~M GABA were acquired a nd analysed using
pClamp suite of programs. The decl ining pha se of the current response was nucd u.sing
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a double exponential equation as the deacy ca n be best described by dou ble xepo nenua l
fit compa red to single exponential. Fi ts to si ngle exponential did not give a better fit to
the experim ental data.
2.7 Analysis of data
Concentration-response relations arc shown by sigmoida l curves expresse d either
as normalized to the maximum response or as a percentage of the co ntrol re sponse .
Concentra tion-response data were fitt ed to the equation:
y ", A + 8- A
1 + (lOCIlO")"
where X = logar ithm of concenrrancn
A = smallest response
B =- maxim um response
C = logarithm o f EC.ID
Hill coefficie nt
Be st lit to the curve was done by the method of non-linear regre ssion anal ysis .
All data were analysed using Inplm (Graphpad Software , Versi on 4 .0) .
Studi es involving interaction between propofo J and flurazepam /zopidone have
been performed ill present of fixed conce ntratio n of GADA, for each parti cular
experiment. Effects of propofo! and benzodiazepine agenists o n control GABA respo nse
were sepa rately measured at specifi c GABAA receptor s. Combination of the drugs was
applied with the same GADA concent ration to find the narure of their interaction at the
GA8A" receptor . Data was interpreted by co mparing the exper imentally observe d effect
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due to the co mbination of the drugs with the the oretical additive effec t of illdiv id lml
drugs , Arithmalic sum of tile effects of individual drugs on thecontrol (GAUi\) respo nse
was considered as the theoretical additi ve response. The effects Oil 1 ' ; ~ I1'" Ilhscf\'ed upon
concurrent ap plicatio n of prcpo fol and tlumzepnnu zopictonc bas been rctcrrcdto as the
experimental observat ion in the result section. The two drugs were flllllll.l ro act in
synergy if the experimental result was sign'i1icantly greater then the uicoretical add itive
response or in othe r word supra-additive, for a part icular prt1pnfnl. llur.rl.cpaml7.llpIChme
and GABA con centrati on, A zero interaction was noticed in ClISCS whe re the Ihc\lfCticOlI
additive and the experimental dat a for the drug co mhmauo n had 1111 signitic:llll differenc e
A negative inte ractio n betwee n the drugs was found where the e xperimen tal 1I;ll a W;IS
lowe r than the theoretical add itive. for the drug combination.
To te st the sig nificance of data , where appruprl ate . repeated measures ana lysis
of variance or ordinary one way analysis of variance coupled with Ncwmau-Kculs
Multiple Comparison s test, or a paired t-tcst was don e, 1\ value lit' p < 11.05 wnv
considered to be significant. Instal (Grapbpud Sonwarc . Versio n 2,(1) was used for
statistical analy sis.
2.8 Chemicals
The following chemicals were used:
Gum agar , trislhydroxymethyllam tncmcthaoc . ethylcm...di'lminc tetraaccric
acid , di methy l sulfoxide, bovine serum albumin , DI.-d ithiothrcillll, cuf'leinc,
theophylline, pyruvic acid, 3·Aminobcnzoic Acid Ethyl ester, GI\H A, mpicl nnc
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(obtained from Sigma Chemical Co.) ; Bacto Tryptone, Bacto Yeast Extract,
sodium uodccyl sulphate, diethyl pyrocarbonate (obtained from BDH); Agarose
electrophoresis get , Bam HI, Pstl . Sea I, Xho I, T4 DNA Polymerase, penicillin,
streptomycin (obtained from Gibco 8RL); rATP , rlj 'I'P, rCTP, rGTP (ob tained
from Pharmacia}; RNAase Inhibitor, m'G (S')ppp (S')G (obtained fromBoehringer
Mannhcim ); Bromophenol Blue (obtained from Bio-Rad): xylene cyanol FF
(ohtained from Kodak); propofol (obtained from leI Phanna ); Intralipid (obtained
from Kabi Pharmacia Canada, Inc.). flurazepam and ROl S·4513 (obtained from
Hoffman La-Roche).
All other analytical grade laboratory reagents were obtained either from
Sigma Chemical Co. or Fisher Scientific Company.
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3.0 Result s
3.1 Cbarac terl zation or GA 8A" receptor s expressed in Xenop lls OOCytl'S
\ iter amplification of c loned DNA for specific GA DA" rec eptor subtypes. c1mlel.i
RNA was prepared from them by the process of in vitro transcription. Recomhimllll
receptors were then expressed in Xellopus oocytes following injection with a c RNA
mixture containing di fferent subunit combinations. Subunits expre ssed in the oocyte
expression system were a l,8{)'l L' aij~"r l L and al(3~ . FollowingcRNA injection . expression
of the recomb inant recep tors in oocytes look 1-3 days and resulted in substantial GABA-
activated membrane currents. GABA was applied briefly (0.5- 1 min) until tile pen!;
response was obtained on oocyres voltage clamped at ~70 mY. Oocyrc s expressing the
Cll13a 2L combination showed a concentration- dependent increase of inward curren t in
response to the applicatio n of GABA (Fig . I). The sigmoidal concentrauon- rcspousc curve
had an EC5(lforGABA of 58 ± 9 pM and a Hill slope of 1.30 ± 0 .07 (n=5). Similarly ,
GABA induced a concentration dependent inward current in oocytes injecled with alJ~""I21.
GABAA receptor cRNA (Fig.2). This particular combination of sub units showed an EC'>l!
for GABA of 67 ± 4 pM with a Hill slope of 1.12 ± 0 .05 (n=5).
Pharmacological characterization of the recombinant receptors cIJllaining the ""111.
subunit was done by using the benzodiazepine agonist flurazepam, which is known 1Il
increase the I OABA on receptors containing "Y1 subunits. Apptlcanon of Ilurazcpam
prod uced a concentratio n-dependent potentiation of the respo nse 10 30 j.L M GAllA (0 = 4)
(Fig .3). Increase in response to different concentrations of GAllA (10, 30, 50 and 100
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pM) was observed with O.S IlM flurazepam on receptors composed o f both al.8:'Y2L and
alia2l. subunits expressed in Xenopus oocytes (Fig.4) . Flurazepam potentiation of loABA
was found to be the grea test whh the lowest concentra tion or GADA (10 pM). The extent
of the potentiation gradually decreased with' increasing GADA concentrations,
The voltage-dependence of the inward current produced by the application of 10
pM GADAwas done on OId3{'(2L receptor combination. The holding potential was reduced
from -70 mV to -20 mV in several steps and ;\1 ~"ch step the response to GADA was
measured. With decrease in the holding potential, the inward current response to GABA
decreased and after a certai n potential the response reversed to an outward current. The
current-voltage relationship is shown in Fig.S. The reversal potential for I OARA was -27.8
± 2 mV (n= 4) which is similar to other published values .
Bicucullinc is a competitive antagonist to GADA on GADAA receptors and when
coapplicd at the concentra tion of 30 pM with 10 pM GABA on human alf32'}'2L GABAA
receptors . it produced almost a complete blockade of the res ponse to GABA (n= 3) (data
not shown).
42
Figure 1. Ccncentratlon-rcsponsc of GADA at human aljl~21. receptor s
a) Current traces showing inward C\"current produced with II range
of GABA concentrations. b) Plot showing response to GABA
(normalized to the maximum-response). Data points in this ,Illd the
remaining figures are ex pressed as the Mean ± SEM. Data Front
5oocytcs.
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Figu re 2. Concemratlun- rcsp onsc to GAD A 0 11 human (Y:(jlYli. n 'l'l'lItofs
a) Current traces show ing inward Cl' cur rent produced with
increasing GADA corcc mmuons . h) Pint showing response tn
GADA (nor malized III the maximum response). lnnn Fnun 5
oocyres.
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Figure 3. Flurazepam potentiation of !cAlIA
Plot shows enhancement of response to 30 JAM GADA with
increasingconcentrations offlurazepam onhumanaJJ f'Y1L GABA...
receptors. Data from 4 oocytes.
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101llurc 4. J<'lur lll.cr :nll poteut la tton varies whh GADA conccntrat ion
a) Dar graph represent ing percentage increase in GADA responses
with 0 .5 JAM Ilurazepam on human crdji'Y~L receptors. 0 ,113 from
7 ooc ytes. h) As in (a) with aJ3~'Y2L GADA" receptors. Data [rom
4 to 8 oocyrcs.
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Figure S. Cumnt-vo1tReerelatl onshlp Cor GABA-2ctlvaled current
The inwardcurrent at adJ2'Y2L GABA"receptors was reduced with
the reductionIn the holdingpotential. Reversalpotential for current
activated by 10 11M GABA is -27.8 ± 2 mY. Data are from 4
oocytes.
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3.2 Propofol and nu nuepam internclitlll at hUlluUI GA8A ~ receptors
Application of propofol to oocytes expressing either CfllJlY~ 1 or UI(JlY:1 rec epto rs
produced a concentration-dependent increase in the response 10 3 IlM GADA. l'ropofol
was applied to oocytes over a concentration ranging from 0.5 to 100 /-1 M. The vehicle
used for dissolving propofot was lntralipid which at a conc entration 01'0.04 and 0.2 %
did not have any significant effect on control GABA response (data not shown) . The
concentration-response relationship for propcto l shows a sigmoidal relationship (Fig.6)
with a calculated maximum potentiation of 75 12% of the 3 p.M GADA response lit the
adJlYlL, receptor. The EC!II' for propo fot was 26 ± 6 ~M (n=7 ) with a Ui1Islope of 1.4
± 0. 14. Maximum potentiation of the 3 ~M GABA response with prupofol at f:(z{JlYII
receptors was 5349 % (Fig.6 ) with an EC\u for propofol of 19 ± 4 ~M (n = 7) lind ullill
slope of 1.3 ± 0.07 . There was no significant difference in the effects of propofol un
GABA responses at alfllYll . versus aJ3lYJI. receptors.
Propofol produced a robust increase in response to GADA when co applicd with
3 /-1M GABA, but the degree of potentiation was dramatically reduced when higher
concentratio ns of GABA were used. Prcpofol (0 .1·20 ~M) was used in conjunction wnh
10 11M GADA on ai3 lYll, receptor subtype and produced a maximal increase uf 949%
of the GABA response (Fig.7). The concentration-response relationship showed an lie ...,
for propafol of 6 ± 1 14M and a Hill slopeof 1.28 ± 0.06 (n=7).
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I"i ~ure 6. IHfects of Proporol on II,AM from oocytes express ing human
rccomhimml GAUA" receptors
a) Current traces recorded from an oocyte expressing a lf32'Y21.
receptors showing pote ntiation of inward CI· current produced by
3 I' M GA llA with application of propofo l (0.5 ~ 100 I'M) . Current
scale for the left three traces is 2 nA and 50 nA for the last two
truces. h) Current traces recorded from an oocyte expressing
0/11 'Y:Lsubtype of GA DA" rece pto r showing potentiation of inward
CI· curre nt produced by 3 JLM GADA. Current scale for the left
uncc IrnL'CS is 5 nA and 50 nA for the last two traces. c) Con-
ccntrarion response curves for a lJ1"12t. (open circles ) and o/1:'Yn.
(closed ci rcll:s) subtype of human GADA" receptors. Dam from 7
o ocyrcs for each uata point.
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.,'il:un' 7. l'ro lluflll t'nh'1I1Cl'lIIl'nt ul" 10 jtJ\1 GAD A res ponse at ~l.811'l' .
receptors.
OIl Current truces representing increase in co ntrol response with
ilppliciIIi(ln of pmp ofcl. Note thaI the current scale is 20 nA for
corurol. 0.5 ant!I JIM propofol. and50 nA for S-20pM propofol.
h i Bc~ 111 sigmoitlal curve 10 the concentration dependent increase
in GAllA fl:spunsc with propofol at huma n Cf,/l~"'11L GAllA"
n.-ccplurs . Ih l;! from 7 oocyn..'S.
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Propcfol also changed the affinity of GABA... receptors to GABA as the
concentration-response curve for GABA was shifted to the left for a~(3lYlL receptor
subtype with the addition of 10 pM propofol (Fig.B). No significant change in the
maximum response was observed with the addition of propofol, but there was a
significant change in the EC)O value. The EC.~ for GABA was found to be 45.6 ± 9 IolM
and 69.7 ± 7 p.M, with and without propofol respectively (p < 0.05), The Hill slope for
the curve with GABA alone was 1.12 ± 0.06 and 1.18 ± 0.22 with GABA plus
propofol. However. propo fol (I p.M) did not change either efficacy or affinity of GABA
at the same receptor co nstruct (data not shown). The e ffec t of 10 p.M propofolon GABA
coucemrarion-response at ad3l "Y!•. receptors could not be evaluated as the data were not
properly fit by a sigmoidal relationship.
Theinteraction between propofol and flurazepam was studied on both a l(3l''Ill.and
f~J3l"Y!I . recepto rs expressed in oocytes. Propofol and flurazepam individually enhanced
1,1...1....andtheir individual responses on control GADA-activated current were added and
compared to the actual response produced by the coapplication of both of them at a
particular GADA...receptor construct, Propofot ( I and 10 p.M)and 0.5 pM flurazepam
both separately potentiated the response to 3 JIM GABA on human a l(31"Yll. GABA...
receptors. but when they were combined, a greater than additive effect was obtained
(Fig.9).
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Figure 8. E(fect ofpropofoloo GADAcon~ntration·respon~crcl;l lill llship
Concentration-response relationshipto GABAalone (closedcircles)
and in presence of 10 pM propofol (open circles) on a ft l"Yli.
GABA,I. receptors. Data normalized to the calc ulated maximal
GABA responses. Data from 5 oocytcs.
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J<"i::urt· 9. ..;rr« t of propofol and nurazepam combination on a,fl'-h,.
receptors
a) Recording Inan a n oocyte showing increase in control (3 p.M
GA BA) response with 0.5 }.1 M Ilurazepam and to p.M proporot
scpurntclyanJ alsn w hen applied in comhhution . Current scale for
the firsl three traces from left is 20 nA and 100 nA fo r the last
two . h) liar g raphs shuwing cumulative data fo r propofo l-
nurazcparn lmcncnon. Filled barsrepresent prop ofol potentiation
of response to 3 pM GABA. Opcn bars denote responses from
GARA,4, reee prors found expe rimentally (E) to the co rcurrem
application of GABA. propofol and Ilurazepam . wh ich are
significamly d ilTerent from the calcu lated additiv e responses (f)
shown by the halche<l. bars. Flurazcpam potentia tion of GADA(3
101M) response was 308 ± 17%. Data from 4 oocytes. • •• p<O.Ol
and .... p< 0 .001.
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The concentration of prc porot also plays an important role in prod ucing the
synergistic effect with 0.5 p M flurazepam. On the OIihYll. rece ptor combination,
propofot (0.5 -10 p.M) shows synergy with 0.5 p.M nurazepam when coapplied in
prese nceof 3 11M GADA, whereas the effect with 20 p.M propafol was not significantly
different from the additive effec t of the drugs (Fig. 10).
Propofol (0.5·1 00 p.M) produced a concentration-dependent potentiation of the
inward current response activated by 3 p M GADA at a iJ i'YlL recepto r. Addition of 0.5
p.M nurazcpam lowered the maximum facilitation of the GADA-evoked response by
propofcl and shifted the tog concentra tion-response curve for pro pofol to the left
(Fig . I I). Theoretical addition of prcpotot and nurazepam pote ntiation of GADA
responses was obtained by ac tual addit ion of responses to both the dru gs. It thus
generateda set of data which can also be described by a sigmoidal fun ction. Specific data
points for this additive curve have not been shown on the graph. The additive curve has
slightly lower maximal response than that obtained with propofcl alone in presence of
GADA, but EC.I II values for propo fol obta ined from both the curves are similar. The EC.IO
for propofol on addition of flurazepam is significantly less compare d to that calculated
from the additive sigmoidal rela tion and propofol alone (Table I).
Synergism was observed with pro pofol and flurazepam at GAB AA recep tors after
the co ncentration of GADA was raised too. At 30 p.M GADA, the combined effects of
propofol (1 , 5 and 10 ~ M) and 0.5 p M Ilurazepam were found to be significantly
diffe rent from the theoretical add itive response of the drugs on human Q"1.Bl 'Y1L GABA"
recepto r subtype (Fig. 12). 0.5 a nd 20 p M propofol failed to demons trate the synergy at
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the above mentionedreceptor. A sim ilar phenomenon wasobservedal U ! (j /'Yll n..'ccprors
where only 0.5. 1 and to /-1 Mpropofol showed synergismwith O.S}l. M Ilurazepamand
30 14M GADA.whereas 5 and 20,...M propofol was ineffect ive inthis respect (Fig.!:l),
Synergism produced by tl urazepam and propofol also varied with the
concentration of flurazepam. Different co ncentrations of nurazcpam (0.25-1 11 M)
coapplied with 5 p.M propofol and 10 "..M GADA produced diffe rent degre s of
potentiation. On al{Jl'Y1L GABA" rec eptors, 0.25 and 0.5 lAM Ilurazepam produced a
synergisticeffect with propofoland GABA. whereas I 11M ffurazcpamd id not (Fig.14),
Ro 15-4513. an inverse agonist at the benzodiazepine site on GABAA receptors.
almost completely blocked lhe pote ntiation of leiM A by I f1M fluraze pnm, hut did nul
significantly alter the effect of GABA alone or with propofol (Fig. IS). Ro 15·45 D (0.5
p.M) when coapplied with propofo l (S 14M). flurazeparu (I ftM) and GABA (10 pM)
produced an effect similar to the prcpofol potentiation of 1,,,,111,' thus co mpletely
eliminating the component of the response contributed by Ilurazcpam wilhout affecting
the response to propofol.
6 1
Ffgcre 10. Erred or Ilropofol and fl urazepam combination on a~{31'Y1I ,
receptor s
a) Current traces re presenting responses to 3 ~M GABA with 0.5
p.M Ilumze pamand 1 pM pro pofol se parately andalso in combine-
tion . h) Sy nergism due to pr opofol a nd flurazepam interaction is
found with lowerconccurrauc nsof propofol (0.5· 10 ~Ml. but nor
wi th 20 p.M propo fo l. Increase in co ntrol response to application
of propofo l is show n by fill ed bars and experimenta l result (El
showing its interaction with fhuazepam is represented by the open
bar s . Hatc hed burs shows theoretical add ition (T) of GABA.
propofol ami Fluraze pamresponses. Enhancement ofcontrolGAll A
(3 ~M) cur re ntdue to flurazepam wa s 308 ± 9%. Da ta from 5 to
9 oocyrcs. " ", (1<0. 01 and ...... r < O.OOI.
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Figure 11. Effect or Ifurazepam on prcporol induced facilitationorGADA-
curre nt in oocytes expressing a:fJlllL receptors
Concentration-response relationship forpropofol (closedcircles)
andpropofol plus0.5~M flurazepam (open circles) in presence of
3 ,uM GABA . The best-fi t sigmoidal curve for the theoreticall y
added responses of prepafol, flurazepam and GABA has been
shownby thebrokenline. Data are from 5 to 9 oocytcs.
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Table I
Effecl of nuraz ep am on llropofol cOII~nl"'lIion.respOlL"l' rel;lli cllIShil) eM:1 ;11
a :8J'tn . receptor in presenc e of J JIM GAllA
Propofo l generales a s igmoiJ.11 conecnrranon-rcsponsc rc l;lIitllt~hip hrllh in
presence of GABA and GADA plus 0.5 I~M Ilurazcpam. ljc sr-Ilt cu rves an :
obtained for propofol alone , experimenta lly observed rcspclnSCfur prnptl f"l plll .~
0 .5 /-1 M f luruzepam (E ) and theoretically ,lIJdcu responses I'm propoful and
fhrrazepam (T) in presence of GABA. Dat a {I..... EC", anll lli ll SIOpc ( ll)! hom
the sigm o idal curves have been com pared . Number of tlhscl'V:llillllSarc illl!il.:lllcd
in parentheses.
'-
Propofol
4245 ± 638%
Proporot + Flurazepam l'nlf'lt,ful + Flur:lA1"un
(E) rn
2718 ± 115%
1.55 ± 0. 18
(9}
4 ± 0 .7 I' M'
1.56 ± 0 .17
(5)
IS ± 5 pM
1.54 ± 11.25
(51
", p < O.OI. com paredto beth propofc l a llllk: and pmpn fnl + nUr:li'.cpiun(l')
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Figure 12. EHret of 31111MGADA on p ropotot and Iluraaepam jnt eractton
on at/JaZL receptors
a) Recordi ng from 'Ill oocy te sho wing poten tiation of OABA
response by Ilumzepnm (0.5 ~M) a nd propofo l (0.5 and 10 }lM)
separately ,1l'KJ upon combined applicationof each conceraratlo ns
of pmpofol with Iluruzcpum . Current scale for the first four trace s
fro m left is 50 nA and 100 n A for the remain ing two tr aces.
11) Propofol (I . 5 and 10 jl M ) in prese nce of 0.5 ~M tt ur azcpam
p roduced potcntiation (E) s ignifica ntly greater the theoretical
additive re sponse (T) , Exper imental observations (open bars) fo r
0.5 lind 20 ~M prnpoful were not sig nificantly different from the
e xpected addit ive results (hatched ha Ts) with flurazepam. Filled
hal'S represent effec t of propofol 011 IG,o,nA' Fl umzepam pnuluced
144 ± R% enhancement o f respon se to 30 ~M GA DA. Data
calculated :IS percentage of 30 ~M GABII resp onses (N =4 ). "'.
p < 0.U5 and "''''. p <O .OOI.
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Figure 13. Effect of 30 #01 7\.'1GAUA 011 propofol and rturazepam interaction
0 11 aJJ2"'1:1.rece ptors
a) Change in the response10 GADA with application of propofol
(0.5 and 5 ptl.l)and Fluruzepam (0.5 J..l~ t ) separately, as wellas in
combination. recorded froman individualoocyte. b) Propofol (0.5,
I and 10 J..l f\.l) and ftumzcpamact synergistically at the GABA"
receptors and theexperimental findings (E) being shown by open
bars has been comparedto the theoretical additive (T) responses
represented by (he hatched bars. 5 and 20 J,.lM :;ropofol plus0.5
pM Ilumzcpam did not produce effects different than expected
additive. Plurazepum increasedcontrol response to 30 J..lM GABA
by 148 ± 3%. Data from5 10 6oocytes . "'. p <0.05. "'*.p<O.OI
and '"?", p<O.OOI.
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Fil:ure 14. Ef fect of flur azepam on pro pofol modu lation of GADA
responses
a) Effect of Ilurazc -am (0.5 and 1 ILM) and 5 IlM propofol
separately on responses to 10 IlM GADA and when app lied in
combination on cx.f3:'Y2l. receptors. b) Lower concentrat ions of
nurazcpam(0.25 and O.5 IlM), denoted by hatched bars were found
to act synergistically in experimental observ ations (E) with 5 IlM
propofol at recombinant CX1(3I'Y21.GAll A...receptors compared to the
speckled bars showing theoretical additive (T) response to the
combination of drugi . Solid bars indicate flurazepam potentiation
of GADA responses and effect of propofol on contro l cur rent has
been shown by the ceen bar . Data from 4 or 5 occytes. • • P< 0,(15
and .., p<O.OI.
a ~ . " r .',l1 1'
'_' . l l l "
~ j ~ I
,oo·,L
",lJll'~t
b
• Flu EJ Flu + SuM PT O (T)
IZ'J Flu + S~ Pro (E)
a
5 uM 25 0 nM Flu 500 nM Flu 1 u M Flu
Pro
CII 600
III5 500
c.<
III 00
&!C§ 400
~3. 300
ClIO~ .... 200
1: 0
CII"" 100l:
~
7\
1II
III 400c
g,<
llllIl1II < 300!XC!)
..... x
o :1 200lilal?-
1:: 0 1001II ....
U
....1II
a. 0
-
A B C D E F G
"igu~ 15. Effects of Ro 15-4513 on propo(ol and nu ree epam respo nses
Ro 15-4513 affects Ilurazepam but nOI propofol response in
presence of 10 pM GABA on human alJ(1 lL G ABA...receptors .
A: Effect of Ro 15-4513 (0.5 ~M) on GABA response
B: Flurazepa m (I J.tM) potentiation of GABA re sponse
C: Almost complete eli mination of Ilurazepam ( I 1l.~ l l restonre i,:,
0.5 J.t M Ro 154513 in presence of 10,llM GABA
D: Propofol (5 pM ) enhancement of low.
E: No significant effect of Ro 15·~51 3 on orccc .;» : : ~ ;,;:.;: • ..
increase in control GABA response
F: Effect of f1urazepamand propofot coapplicarion on 1<1.\1',\
G: Ro 15-4513 decreases response to ccapplied rlurazcoam ;).1:":
prcpofcl to the level of propoiol alone
Data from 4 occytes.
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3.3 Interaction between prepor cl and zoplclonc 011 GABA" recep tors
Cyclopyrrolone derivatives have been found to potcmlate thl;'effects of GAllA.
Zopiclone,included in the class of cyclopyrrrcloncs and classified as i t full agonist i ll the
benzodiazepine site. was tes ted for its action 011 inward currents activated by 10 11M
GADA on the a i/3aIl.(benzodiazepine type 1) receptor. Di-methylsulfoxidewas used as
a vehicle to dissolve zopiclone and was found 10produce very slighl inhibitionllf GAllA
current at a concentration of 0.05% (data nOI shnwl1). Zopiclonc (O.OS-SpM) increased
the control response to 10 p,M GABA with an EC11l of 107 ± 9 nM (Fig. lo). Till'
sigmoidal concentration-response relationship almost levelled off al higher zopiclouc
concentrations with a maximum potentiation of 232 ± 5% and a Hill slope of 1.26 ±
0.08 (n=8) . Maximum effect of zoplclcne was compared 10 10 p,M fluncc pam. a
maximally effective concentration of this bcnzodiazepine agonist. Zopiclonc was fouud
to produceequally effective responses as Il uruz epnm. Unlike Ilunlll:pam. zopic fonc (0.1
p.M)when combined with propofol (I or 10 p.M) and 10 p.MGAllA not only lilik'll ttl
produce an effect greater than the expected additive effect. but actually produced an
effect significantly lower than the theoretically additive response (Fig. I?).
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I' ia.: llrt, 16. Err«( or zo piclone on GAIIA·a cliyat ed cur rent a t 0II3,'YJI.
receptors
a) Currenl trace s frum an oocyte mowing increase in IGAM on
application of 0.5 - 5 pM zopiclone and also potentiation or GABA
response with 10 ",M flurazepam. b) Pial showing concentration-
dcpcnderu relationship of zopiclone topen circles) to potentiate
I(J....... Zopiclo re is equally effectiv e in produci ng a change in the
GADA response as Ilurazepam (10 JIM. closed circle). Data fmm
9 oocy tcs.
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l:i ~lIrc 17. Negati ve tnt cra cnon bct wcen prcpo fol and aopl etono 011 011#11:1.
GADA" receptor
a) Response to GABA in presence of zoplc tore and propofol
separ ately and in combination. shown as recorder from an oocyte .
b) Change in lGAR" on application of eopcl cne concurrent ly with
pmpofol (spl...ck led bars) produced response (E) which was
significantly lower than the theoretical additive (1) response of both
of the drugs (halched bars ). Filled bars show effect of pro pofol on
inward GADA cu rrent and response 10 100 nM zopiclone is
represented by the ope n bar. Data from 5 or 6 occyres. • • • •
p <O .OOI.
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3.4 Effect uf propofol on GADA" receptors with and wilhout 1'11, subunit
The response to GADA at the (t lflzcombination of human GA DA" recepto rs were
smaller in magnitude compa red to the responses found with receptors contai ning the 'Yl l
subunit. Mon..'Over the response reached a maximum at a lower conce ntration o f GADA
compared to the other recep tors.The recep tor had an EC50 o f 8 ± 2 11M (or GADA with
a Hil l slope of 1,23 ± 0 . 14 (n =8) (F ig.18) . No intermediate concentrat ions of GADA
were used between 1 and 10 11 M. For this receptor co mbination , effects of these
intermediate GADA concentrations are important as they arc around the median effec tive
concentration and co nstitutes an important portio n o f the curve. Inclusion of these GABA
co ncentrations might alter the Hill slope slightly .
Propofol which facilitated the GADA response at al3'Yreceptor construct was also
found to enhance the GABA~ac tivated inward current at the ai31 recep tor . Unlike
proporor. flurazepamwhich potentiated theresponse at GABA A recep tors having the 'YZl
SUbunit. failed to enhance the ef fect of GABA at a J31 rece ptors (data not shown). T he
response to 3,1M GADA was increased by propofol (O.5~20 ItM) with an EC~ of 8 ±
I 11M (n=6) (Fig. 19). TIll': hill slopewas 1.78 ± 0.19.
T he respo nse to propofol was compared on both 0ij31'Y2l and aJJz receptor
combi nations with equivalent concentrations ofGABA. Fro m conce ntration-responses of
GABA at both the receptors. 3 and 30 p M GA BA were found 10 produce a response
close to the EC.~. va lue at aJJ l and al3z'YZl. respectively. The effec t of higher
co nce ntratio ns o f proporo! (10 and 20 p M) was greater at the al3z subtype of receptor
than at the all3l'Yll . receptor construct, with eq ually effective concent rations of GABA for
78
each receptor type (Fig.20).
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Fij,(ure IH. tncrcn se ill GABA medi ated response on «lJ l combinatio n of
GADA" receptors
a) Rnw current traces recorded from an oocyte show ing increase
in GADA-activ.llCdinward cur rent at ail2 receptors on application
of increasing GABA concentratio ns. b) Cumulative data showing
log-concentration response relationship for GABA on human aiJ:
subtype of GABA" receptors. Data from 6 occyres .
-6 -5 -4 - 3
Log [GABA] (M)
a
b
. ,.
r
I
1:: 120
t
.... 100
::l
(.)
~~ 80
rIl ::l
&!: 60
0-
"C E
.~ -e 40
ro
E 20
....
o
:z: 0'---==---'---1-- ----'- ------'
-7
81
(I) 1100
UI
c
0 9000. <Uloo(1)<
O::~ 700
'\3::<:
:1
(I) 500OlM
Ol
1:: 0
(I) ..... 300
u
...
(I)
0- 100
- 8 - 7 -6 -5 -4
Leg [Propofol] (M)
Figure 19. Facilitation or GADA-activated response on a~J receptors by
proporol
Concentration dependent enhancement of response \0 3 pMGAllA
by propcrcl (0.5·20 ~M) . Each pointis datarrom 6 oocy tcs.
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Figlcl"e20. Effect of "I'lL subunit on pro pofol mod ulation of GA BA,\
receptor functi on
Degree of propcrot(0.5-20 I'M) potentiationar equivalent (EC;o)
concentrations of GABA on CXj31 (j I'M GABA ; open bars) ami
ali31'YIL (30 JIM GABA; filled bars) receptors. Modulation of
GABA response at a :fJ! receptors is significantly greater wit'i 10
and 20 I'M propcfol Ulan at the OI~lllL receptor co nstruct. Data
from6 occytes.". ", p<O .OOl.
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3.5 Effect of proporol 011 GAScA" receptor d l'Sl'IISilh:al ioll
Application of higher concentrationsof GABA10 GABA,\ recepto rs results in the
generation of a transient inward current whichdesensitizes rapidly ,IlIU rcaches a steady-
state current amplitude. 250 11M GABA produced a fast inward current response al thc
Ct'1.8lYll.GABAA receptor where decay of the current during the descnsitizatiun phase can
be fitted by a double exponential equation. Combined application or (i J\UI\ and prupoful
did not change the characteristics of the tmns;enl current h UI caused a th,\ll~e in Ihc nuc
of desensitization and steady-state current amplitude as well. Raliuof SIClllly state ttl pcak
current amplitude showed a significant increase afte r adding 10 11 M propofnl with <iJ\BJ\
(Fig.21) . Absolute current amplitude for peak and sl...ady stale or the GAllA reS[XHlSC
when compared in the presence and absence of propofol showed clearly thaI propnrnl
caused a significant increase for both the components (Fig.22). Ik sl lit I l l" the double
exponential showed that propofol induced no change ill time constant fur the Iirs!
exponential phase, whereas the second phase was signiflcently increased (Fig.2J).
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F il:llrt· 2 1. e hilllgl' ill steady sta ll' tn peak curre nt ra tio a rtcr co m hining
pro pcful with GAUA
al R CS('Ill l 'iC fro m au ooc yte showi ng ef fect of 250 ~M GA DA on
u...'SCll"itil.iltion of the re~n.'il: Wilh and without propofol at lhe
l't1{J~..,!1. receptor construc t.
hi Effcc of 10 pM propofcl u n thl: steady slate to peak curre nt
amplitude ratio pnllluc t,.'<!hy 10 p.M GADA at the (Y 1{i:..,.~1. GADA..
rece ptor . I'm poli ll ca used ;1slg uiflcancc increas e in the ratio h)'
increa s ing the stc<ldysuuc current amplitude . Daur from 5 0ocyles.
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Figure 22. Errett of propofol 011 GABA-l1ctivated peak and steady state
current
Applicationof 10 ,uMpropofcl causedsignificant increasein both
peakas well as the steadystatecurrentcaused by 250 JIMGABA
at human adj {Y2L GABA... receptors. Data from 5 cocytes. . ,
p<:O.02 and ..... p<O.OOOl.
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figure 23. Effect of pru pclol on ra te of desensitizati on of GAllA respenses
Desensitization of GABA -activated current was filled hy a doub le
exponential relationship. Additionof 10~M proporol with250 pM
GADA did not change the first time constant (T.) , whereas the
second (Tl) was longer. Data are fromS occytcs. .... p< O.OO3).
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4.0 Discussion
4.J Characterization of recombinant GAHA...receptors
Recombinant GABA" receptors expre ssed in different batches of oocyres coming
from different frogs had the subunit combinations of o:l12"12L' o:l32"12L and o:lJ2• Fo r all
the experiments performed, a steady voltage clamp of oocytes at -70 mV was maintained.
It is a widely observed phenomenon that GADA induces a concentratio n-dependent
increase in lhe receptor response which ultimately reaches a maximum leve l. GABA at
lower conce ntrations docs not produce an apparent receptor desensitization , whereas this
becomes quire prominent with increase in the applied GABA concentra tions. GABA
activated responses at the 0I1112"11L and O:ll12"12L receptor construct had an EC,o of 58 ±
9 p.Mlind 67 ± 4 p.M, respectively . Simi lar results have been obtained by other groups
with (Xj(J l"l ll . GA BAA receptors expressed in Xenopus oocytes where GABA had an ECso
of 46 ± 3.6 p.M (I). Benzodiazepine potentiation of the GABAA receptor response is
only observed at receptors having a "I subunit. Oocyres injected with the 0' 2(32"1L receptor
suhunit messages were found to produce a concentration-dependent increase of the GABA
response on application of flurazepam. Flurazepam potentiation of GABA-activated
responses was found to vary with change in GABA concentr ation at recep tors containing
the "I l l. suhunit. Benzodiazepine potentiation of GABA response was seen which verified
till: expression of the "I2L subunit. The 011(32 subtype of human GABA" receptor was
expressed in oocytes and had an entire ly different pharmacological profile compared to
the receptors with three subunits. T he EC50 for GABA at 0'112 receptor construct was 8
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± 2 JlM which was quite low compared to the other IWO types of receptor . This is
similar in findings with other groups, where EC1nfor GAllA at receptors wlrh f'fl and n:
separat ely with the {3 subunit expressed in oocytes was 1.3 ± 0.2 and 12 ± 1 I,M
respectively (46) . Moreover , Ilurazcpam (10-100 JlM) which p\llcillimellGAnA~aclivmed
responses on the )' IL conta ining receptors, failed 10 facilitate lhc respu\\sc OI t rr..iJ ..
receptor. The distinct pharmacological profi le of the receptors is conststcm with
express ion of specific receptor SUbtypes in oocytes . All the rccouumuur GABA.\
receptor s produced an inward current in response to GABA and thc current-voltage
relatio nship showed a reversa l potential of -27 ± 2 mv , similar II I values plIlllished hy
other researche rs. The reversa l potencialfor the GABA-cvokcd current ,II flliJ : receptors
is reported to be ·20 mV under simila r experimental conditions (I I). The reversal
potential shows that Ihe currents evoke d hy GAllA were inward chloride cu rrcms.
Bicuculline is a co mpetitive nntagomst at GABA site of GABA~ recep tors and it was
found to almost complete ly elimi nate responses to GAllA at a dJ!)'ll . re ceptors . This
prov ides additional evidence thai the inward curren t was med iated through GAllA...
receptors .
4.2 Synergi sm between prepefcl and Ilu r axep am on the GAUA-;lcti vatcd rece ptor
respon se
Propofol is widely known to act as a positive modulator at the GA llA,.. receptor
site (27,48,30,29,12). Propofol has been found to influence hinding or diffcr em drugs
to rat cortica l membra ne preparations. It increases blueing of [JII I·GAIIA, reduces
90
binding of rl$S/-TBPS and enhances GADA and musctmol st imulated CI· uptake (15,62).
Propofol al pharmacologically relevant concentrations potentiate membrane currents
activated by exogenous and synaptically released GADA (60). Propofol was found to
robustly facilitate the GADA-evoked responses at both the cx1(3l Yll, and CXl(32'YlL subtype
of GADAA receptors. Modulation of response to 3 p.M GADA by propofol at both
receptor types produced similar EClll values. Propofot enhancement of the GADA
response reaches a maximum, which is dependent upon the concentration of GADA
employed. Coapplication of propotor with 3 p.M GADA produced an enhancement upto
8000% of the control GADA response, whereas the facilitation dropped to 949% when
thc concentration of GADA was changed to 10 «M. and less than 500 % with 30 p.M
GADA. This is mainly due to the fact thai propcfol is unable to increase the maximum
response that can be obtained by a saturating concenrrarlcn of GADA at the receptors
(Fig .B). With the increase in the concentration of GADA, the control response increases
and as a result the degree of modulation by propofol decreases, because the maximum
response level remains constant. Although the facilitation of control GADA-evoked
current by propofol decreased with increase in GABA concentration, the EC5ll for
prepofcl at the CX I(3{YlL receptor was reduced, when applied with 10 p.M GABA.
compared to 3 p.M GADA. This shows that GABA changes the affinity of propofol
towards the GABAA receptors. Whether GADA changes the efficacy of propofo l at the
GADAA receptors, is diffi cult to predict as the data is insufficient to draw any
conclusions.
The maximum response produced by GABA in presence of 10 p.M propofol was
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not significantly different from thai produced by GABA alone (Fig. S). Pmpnfol changed
the affinity of cx:I1:'YJL receptors for GABA hut did " O( change the efficacy which ls
similar (0 results with GABA" receptors on dissociated hippocmllp:l1 neurons. where I
and 5 ~M propofoll owered the EC~ll for GABA (29). 111is probably shows nuu p1"l1[1n li.11
also changes the affinity of GADA towards the receptors.
Propofol enhances I"'Hl-flunilrazcpam binding to r at hruin membranes in a
physiological salt solution with an EC~l of 23 ~M (63). Intravenous udminixtration Ill'
propofol produces a dose-dependent inhibition of rat pars reticulatn neurons tiring which
was reversed by picrotoxin and bicucullinc and was enhanced hy diazepam . l lowcvcr.
the benzodiazepine antagonist Ro 15-1788 had lin inllucnce on the effect til' pml'llflil
(62) . Moreover . propofol-induced current in acutely dissociated lnppocampalncunms was
facilitated by diazepam and not by pentobarbital (30) . Propoful shews an additive effect
on GABA and TBPS binding in rat cerebral cortex with diazepam (13). III cl inical
studies. propofol and midazolam were found 10 act in ~ynergy for the induction of
anesthesia (72. 10). Temazepam also significantly increa sed the time fnr cognitive
recovery in patients anesthetized with propofol and alfcntanil (4).
In the present study. low conccr uranons of propofnl (0.5-10 14M) when Ctlilpplied
with 0.5 pM flurazepam were found to syncrsistically po tentiate responses 10 311M
GADA at both Cfll1z1'2L and aJjl'f2L receptors. At the highest concentration (20 /lM) of
propofol tested . the potentiation of GABA receptor-activated membrane current ( lfjf\M)
by the combinati on was not different than the theoretical additive response. Al (Xl tJ'Yll
receptor flurazepam produced a significant decrease in the EC..., concentration for
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prnpoji)l without increas ing the maximal potentiation of I c;ABA obtained with propofol.
Thus, it appears thar Ilurazepam (and presumably other benzodiazepine receptor
agonisrs}, in addition to facilitating I (; AI/A on its own. also increases the affinity of the
receptor for propofol, resulting in a greater than expected potentiation of IGAII>I. by lower
concentrat ion of propofol. As the concentration of propofol approaches the maximum for
potentiation of IOAIIA' any increase in affinity induced by flurazepam becomes negligible.
This idea is further supported by the results obtained with different concentrations of
GAlJA. A greater than additive interaction between propofol and ttcrazepam was very
pron ounced when 3 1LM GADA was used. However. at 30 ~M GABA the difference
between the theoretical additive response and the experimental response became smaller
and more variable. II is expected that higher conce ntrations of GADA (50·\00 1LM) .
which approach the maximal current amplitude. would also prevent any synergis tic
interaction between propofol and Ilurazcpam to potentiate I OAnA'
The lack of synergy bet '..'een propofol and flurazepam with higher flurazcpam ( I
11M) conccntration is more d ifficult 10 explain. However . it is possible that high
concentrations of benzodiazepincs might interact with propof ol in presence of GABA to
produce a less than addit ive response for both the drugs . Further exper iments using
higher concentrations of Ilurazepam (5·20 I'M) will be necessary to test the hypothesis
thnt the interaction between propofol and flurazepam is biphasic.
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4.3 Zopiclonc negatively interact s with prupofol 011 GAllA.\.rl,(·l'l'lllr· :lclh ';lll'd
respons e
Zo piclo ne , classified as a full agonis t at the benzodinzepinc silc. is u l'l\IICIll
allosteric modulator of GABA...receptor funcuou and IS known Ul huvc hY\lllllUC :1111\
anxielytic properties similar to bcnzodiazepincs. Zopiclonc produced a dusc.dcpcndcut
facilitation of GABA response which reached a maximal level cmupamhle to the effect
produced by maximally effective f'lurazeparuconcentration. Like diazepam. zopiclonc
also stimulates [ )~Sl-TBPS bimlmg to rarcortical ruemhmnes (16) and the C~lC I1l Ill'the
TBPS binding shift givesn measure of efficacy, suggesting znpreloncas a full ag.ullisl.
Cyclopyrrolones havealso been found til inhibitbindingof 1-'III·henzoJ iazepincs hI hrain
membranes (7). Study of the kinetics of interaction between 1-\11 [-Flunuruze pamnnd1'111-
suriclone with lhe GABA,., receptor have proposed that hCll l.lIdial.cpillCS aml
cyclopyrrclcnes bind to two distinct, but allosterically coupled sites 0 11 urc GI\IIA,.,
receptor (87). It was also suggested that the conformational stale of the GAllA...receptor
on benzodiazcpine binding is different from thar of cyctopyrrolouc binding.
Benzodiazepine binding decreases with increasing temperature (H.H7 ). whereas the
binding of cyctopyrrotones remains unaffected. This implic!\ thai the former is
predominantly enthalplcally driven while the latter is driven er nropicatly ( I1.M ), In nIt
brain membranes photolabelling with nunitrazepam produced nmctivution or Ihe
benzodiazepinebinding site, whereas binrJing for cyclopy-nlonc I,llll·suriclnne remained
unaffected (16) . Irreversible loss of binding sites for bcnzodiazcpine on rolt brain
membranes was produced by dicthvlpyrocarbonate (DEPC) trearmcm hut the same
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procedure was unable 10 mcKlify suriclone (a cydopy rro lone der ivative) binding. In the
present -audy . propnfo l produced an effect in comhinarion with zopid one which was
:,ignitkHltlly lower than the add itive response This might he due to some overlap and /or
uucrncnon between the binding sites of propofol and zoptclone on GABA", receptors.
Alternatively. there may be a negative alloster ic interaction between zoolcrone and
prupufol which results in a tess than additive response. In either case, these data support
tile notion thllt benzodiazcpines and cyclopy rrolones mod ulate GABA",receptor function
viadiffcrcm mccharrisms
4.4 Role of "hI. in pro pofol potentiat ion or GADA response
With equivalen t conccntrauons ofGA BA. enflurane prcduces sigruficantly grea ter
rCSfHlO!iCS l it ('r IP I receptors than at Qll3 (Y~I. receptors expressed in Xenopus oocytcs (47).
Pmpnt()1similarly produces potentiation of equivalent GADA-activated responses on both
fl~f1! ,LIlU «~J3~')'~I. subtype of human GADA",receptors. Significant enhancement with 10
and 20 11 M propofol at the a~l3! receptor over the a2{JlY1L receptor suggests propofol
potenn.uion of GADA response is not dependent upon the prese nce of the i' 2Lsubunit.
Moreover. it seems that absence of the i'2Lsubunit helps in more efficient modulatio n of
GADA", rct;cptor activated response with pharmacologically relevant co ncentrations of
propoful. It is possible that there are higher affinity binding sites for propofo l on
receptors composed o f er{J compared to a'3')'~ subunits. or a{Jreceptor combination m ight
allow greate r allosteric modulation between propofol and GADA binding sites. Furt her
experiments will he needed to clarify this point.
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4.5 Propofol and benzodlazepln e act a t different sill's on GAIlA\ receptors
In rat cortical membranes proporot failed 10 displace fjunurazcpnm front ilS
binding sill.' indicaling th e omding sill.' for rropofol is dltfcrc n t than thai for
benzodiazepines 0 5,62). Coappl ication of propofcl with either lllrlms-ah)llC or
pentobarbital on rat cerebra l conex membranes produced an add itive iuhibainn of Till'S
binding. thus providing evidence for separate l1inding sites of mcsc drugs (1:\ , 15).
Propofol potentiated IG\ BA o n bovine chromaffin cells and rat con ical ncurons and till.'
enhancements were not influenced by benzodiazepinc ant:lgn nisl Ilumazcnil. Tlus is
highly suggestiveof separate siteso f action for propofol andhenzodi:u.epincs uu GABA"
receptors (27) . Ro 15-4513 , a partial inverse agonist at the tc nzodazcptuc SiIC,
complete ly eliminates the flurazepam facilitation of lhe GAll A response hut II;IS no
influence onthe modulatory effecto f propofol. Combined nppl lcutinnof GAllA . pwpnfnl
and flurazepam in presence of Ro 15-4513 totally abo lishes the Ilurazcpam component
of the response and produc es only the propofol enhancement of the GAllA... receptor-
activated response . This particular ph enomen on is only possible if lin: xitcs of action for
propofol and benzodazepin e on GABA" receptor M C differen t. That prupofol aml
benzodiazepines do norshare a common binding site is again obvious Inrmthc tact IIml
latter has no action on cx(Jreceptors , whereas, pwrlofol pcsutvet y modulates the respnnsc
to GADA, and indeed was more effective as a modulator of GABA resp uiscs in the
absence of the "1'2 subunit. Ot her researchers (70) have suggested the imp ortance of the
(j subunit for the effectof pro porol on theGASA" receptor. They have shownlhOl t direct
activation of homomerlcjf GABA receptors withpmpofol and pe ntobarbital hut nut with
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the stero id anesthe tic alpha xalone. Again, the direct activation of the CI "current is more
pronounced at (31 receptors compared 10 receptors containinga, and/o r 'Y2Salong with the
131 subunu. Benzod iazepine pharmacology at GABA" receptors appears to be influenced
primarily by c and 'Ysubu nits. whereas the {J subun it is not known to have much of
effec t. T he (Jsubunit seems to be important for atleas t one effect of p ropcfol. the direct
ecuvauon of the GABA" receptor ch loride channel. A great de al of wo rk remains 10be
done in order to cl arify the role of individual subunits in propofol modulation o f GADA"
receptor function .
4.6 Propofol decreases GADA" receptor desensitization
Inward curre nts acti vated by higher concentrati ons of GABA rapidly rea ched a
peak response foll owed by a decline to a steady-state level. The time course of receptor
mediated current decay can bebest described by two exponentials. Add ition of propofol
with GA BA increased peak current amplitude . but had a much more d ramatic influence
on thc steady-state current . Propofol coapplied with GABA did not a lter the ea rly. fast
time co nstant of current inact ivation (Fig.23; 60), but signific antly prol onged the slow
lime constant of decay. At higher GA BAco ncentratio ns, propafol did not alter the peak
inward current response. It is possible that the peak GABA respon se aft er application of
high GADA conce ntration is underestimated due 10 the desens itization occuring during
the onset of the response. Co-application of propofol and GA BA has been repo rted to
increase the freque ncy of G ABA" receptor channel opening (60) which is possible if
pr opofol interacts with the GABA recognition site to allosterica lly modulate the receptor-
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channel comp lex. Propofol has also been found to Increase the steady-stare current
amplitude of 'CAB!< (60) . This suggests that propotnt may shin the equilihrium Il l' the
receptor population from desens itized non-desensitized slates. T his finally enhances
receptor mediated inward current response during the steady-state.
At synapses, following an act ion potential the synaptically released GABA is
pre sent in a saturating concentra tion. The concentration then decreases due ro reupmkc
of GABA into the presynaptic nerve terminal lind metabolism by GAllA-T . Propofot
changes the timecou rse for current decay of synaptically evoked GABA responses ((0),
bu t is probab ly not capable of changing the maximum response to GAllA. Purcntiation
of GABA evoked responses ca n be seen with pmpofol, hut the magnitude is inversely
pro portional to the concentrati on of GADA employed. In synaptic events , during the
decay phase of the GA BA response, (he effect ofprupnfol would he expected IIIincrease
as the concentration of GABA steadily declines. Propofol would a lso red uce the rate Ilf
decay of the GADA-evoked re sponse , thus increasing the decay time nf the inhihitnry
current. An apparent increase in the decay time of the receptor responsecouldlllsl} occur
if extrasynaptic receptors, not normally activated bysynaptically rel eased GAUAbecause
of the limits of diffus ion, become activated in the presence of pro pofnJ. Propufnl when
coapplied with GABA could inc rease the response at cxtresynaptfc receptors . possible hy
direct activation of the receptors o r by increasing the response to suhs<lturating
concentration of GABA which reaches those receptors. Alternatively, there may he a
subset of "silent" receptors which a re not activated even in the presence of high
concentration of GABA. These receptors may be activated hy pr opofol which would
98
result in an increased current amplit ude du ring the steady-state respo nse. If this is true ,
then the peak c urrent would be exp ected 10 increase during the comb ined appli cation of
the drug s, hut synaptic studies suggest that the peak amplitude rema ins the same while
the decay time and curre nt increas es. The former argument is thus fa voured 10 explain
thi.~ part icular e ffect of propofol a nd hence the increase in dec ay curre nt is thus probably
due to redu ced desensitization o r involvement of extrasynaptic receptors. These two
effect s of propo fol wou ld be expec ted to significantly enha nce the inhibitory effect of
GADA al the synapses. Althoug h the specific action of propofol at synapses is not
known, the ultimate outco me is the prolongation of the inhibitory synapt ic events.
4,7 Conclusions
Prupcfol and nur azepam, which have independent effects at GABAA receptors ,
were found to produce a greater than additivepotentiation of GABAA recepto r function.
fbis e ffect could beattributed to a flurazepam-induced increase in the affinity ofGA BAA
recepto rs fur proporot. Th e combination of propofol with zoplctone re sulted in a tesstha n
additive potentia tion of GABA receptor-activated membra ne current, sugges ting that
benzodlazeplnes and cyctop yrroton es have distinct sites andl o r mecha nisms to modulate
GABAA receptor function. Propofo l and benzodiazepines do not act a t a comm on site on
the G ABA... receptor since RO 15-4513 , which completely block s the effect of
flurazepnm. d id not aller the potentiating effect of propofol. Both the efficacy and affinity
torpropofol at me GABA...receptors changed depending upon the presence and absence
of the 'Yll subunit along with the Q" and (1 subunits. Howeve r. no sig nificant change in
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the effect of proro fol was found with the chan ge in the C't subunit isoform of the GAllA,\
rec eptor . Propofol also was found to decrease GABA...receptor dcscus nlz..anon . which
coul d be due to changes in desensit ization ki netics.
4.8 Future directions
The nature of interaction betw een pr opofol and bcnzodi azcpinc site lig;1I1US has
been examined and it was found that a sy nergistic interactio n betwee n prupo fol and
tlura zepam can be seen at the GADA .... receptor level. Further work needs 10he don e with
other benzodiazc pines , most notably midazol am which is used cllufcalty , IIIdete rmine if
thi s type of synergistic intera ction is true bet ween pro pofol and other bcuzodiazcpincs.
zoplclone. which is chemica lly unrelated to the benzcdinzep incs . produces 1I
negative interaction at the GABA.... recepto r when combined with pr opofot. ThlMlgh
equival ent degrees of pote ntiation were obtained witb different co nccrmuions of
zo plclcne and flur azepem , these drugs pr oduced enti rely di fferent responses when
co mbined with prop ofol at the GABA...rece ptor. To ensure that there is true negative
allosteric interaction between tbe sit es of action of zoplclonc and b cnzodlazcpinc.
e xperime nts must be done with both lower (50 oM) and higher (500 nM) concentrations
of zopiclone. There might be a possibility of finding some diff erent kind uf inte raction
bet ween propofol and lower concent ration of zopiclone. This is suggested becaus e of tne
los s of sy nergism between propofol and a hig her co ncentration of Ilu razc pam ( J /1M).
Co ncentrati ons of zopiclone used for the pre sent study arc equ ivalent to the EC.\l1value
and so it might be a good idea to e stablish the fact of negative interac tion with b oth
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lower and higher concemra tions of thedru g.
To lind out if th ere is a ny physico-chemical interac tion betw een pro pofol and
benzodiazcpines which pr oduces the observed syne rgism, the effect of combinin g t~ two
drugs can he tested on the 1l{J sub type of GABA... receptor. Thi s will be the ap propriate
receptor combination to test this idea as be nzodiazepinesare known to have no effect o n
aBreceptors. whereas pr opofol m odulates theGA BA response on thi s receptor .
Subunit dependence of propofol ha s been studied by changing the a: s ubunit of
GABA...receptor and the action of propofol alone or in combina tion with o ther drugs
seemed 10 he independent of the a subunit isofonn s. Thepresence of di fferent a subunit
isoforms are known 10 impart different benzodiazepine pha rmacology to th e GABA...
recept or . Thoug h there is nomajor difference between III a nd Ci1 subunits on the ability
orpr oporot to modulate GABA cur rents, additiona l a subunit isoforms can be looked at ,
in co mbination with the f3 and "y subunits, to find out the effect of this SUbunit, for
certain, on proporolsact ion.
Presently, reports indicate that the action of propo fol is de pendent on the (3
subunit. To les t contribu tion of the Psubunit, express ionof cry1subtype is necessary 10
compa re theeffectof pro pofoIwit h both01(3andaJ31': GABAA receptor subtypes . Change
inthe asummit isofonn is needed to find its effect on thepropofol modul ation orGA BA-
activa ted receptor response . If potency. affinity or efficacy varies wi th the change or
elimina tion of the Ii sub unit, the n it can be suggested that the bind ing of prop ofol is
depende nt upon the presence of the (3 subunit isofonn, The a subunit might be
particularly important for reduced desen sitization of GAB AA rece ptors ind uced by
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propofol . To findout the importance of B subun it in uescnsnlzano n. experiments should
be d esigned to lest th e desensitization kinetics of GABA response with rropofololl both
try2 and a{1'Y~ receptors having differen t {3 sub unit isofonus . T his will g ive an idea
regard ing the specific (J subuni t involved , if at all. in the binding uf prupofol to lhe
rece ptor and inOuenci ng desensitization .
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APPENDIX I
Solutions
Transfection or micro-organ ism with eDNA
Pre pa ra tion or liq uid broth (L O):
1% w/w Bacto Tryptone
0.5 % w/w Bacto Yeast Extract
1% w/w sod ium ch loride
disti lled water to make up the volume and adjusted pH to 7.0 with NaO Il
Pr eparation of Tr is-EDT A (TE) BuITer :
50 mM Tris[hydrox.ymelhyl]aminome thane pH 8.0
I mM ethylenediamine tetraaccnc acid (EDTA)
Max i plasmi d prep a ration
Solution 1
50 roM glucose
25 mM Tris pH 8.0
10 mM EDTA pH 8.0
112
0.2 M NaOH
I % Sodium dodecyl sulphate (S US)
(Made up fresh before each
plasmid preparation)
Solulion 3
For 100 mL:
29.4 g KOAc
6.26 mL glacial eceuc acid
distilled water to make up volume
«:Ied roph orcsi!'iGel
lOX Tris borate EDT A bu ffer (TBE):
108 g Tris base
55 s hark acid
40 mL 0.5 mM EDTA pH 8.0
dH10 10 make up volume to I L
autoclaved.
2. lOX loading buffe r:
O.42lJ, bromop henol blue
O.42 lJ, xylene cyanol FF
25 % ficcl l (Type 400: Phannacia) in water
3. 1.0% agarose gel
113
S2JlUiJllU
TE buffer:
50 mM Tris pH 8.0
1 mM EDTA
In vitro transcription
1. 5X transcrip tion buffer (5X TB)
200 mM Tr is-HCI pH 7.5
30 roM MgCl l
10 mM spermidine
10 mM Nae l
Made up in DE PC treated water , f iltere d , ste rilized lind stored at -2Ir C.
2. Bovine serum albumin 2 mg/mL (Grade V)
3. 100 mMdrthiothreitol
4. rNTP mix
For SILL:
10 mM rATP - 2.5.ttL
10 roM rUTP • 2.5 j..lL
tomM rCTP • 2.5 n l,
DEPC water . 0.5 ILL
5. 0.5 mM rGTP
6. DNAase buffe r
10 mM Tris pH 7.5
5 mM MgCJ2
10 mM NaCI
DEPCW aler
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7. Restriction enzymes
Bam m for human U I cDNA
Psi I for human U 2 eDNA
Sea I for human fJ2 eDNA
Xho I for human ")'21. eDNA
Oocyte storage solution
NaCI- 88 mM
KCI - 2 mM
CaC]l- I mM
MgCI1 - I mM
NaHCO}- 2.4mM
HEPES - 5 mM
pyruvic Acid - 2 mM
caffeine: or theophylline - 0.5 mM
penicillin - tOO UlmL
strepromyctn - tOO ~g/mL
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lscbote anah'sls of interaction between propofol and flura zepam
GABA·aetivated inward current was potentiated hoth hy 1'r('poli,1:mt.l tfurazcpam :11 the
ct2{Ji'hl GABA" receptor. An effect level was :lrhilrarily choose» Front the concentration-
response relationships of propofol (Fig.A) and Il urazcpnru(l;ig.B) in IlreSCl1CC01"30 11MGABA.
A 170 % potentiation of IU/lIIA was produced by ..U i JIM and 1 11M 01" pmplIfol and rtumzcp am
respectively. The analysis was carried out according to the method described hy ncrenbauru.
M.C . (What is synergy? Pharmacol . ReI'. , 41 (1989) 93· 141), Combined application of O.S /IM
flurazepam with propofol (0.5 - 20 11M ) shows a conccnrnuinu dependent response (Fig.A).
Concentration of propofol in presence of O Ur:l 7.CP;1111 producing the dcsinxl effect W, lS culcuuucd
from the sigmoidal relationship. Points joining the conccnunnon or Ilurazcpam aml pwplll"ol
producing 170 % augmentation gives a straight line (Fig.C) and any lIolla point fur the cmuuincd
effect of the drugs falling on that line is indicative of zero intcmctlon. Comhination Ill'pmpnlill
and flurazepam which produces 170% enhancement of I l i o\l ~A f' llls far Iu the left or the Sll1lighl
line on the graph, thus showing that the drugs act in s}'ner~y (Fig.C).
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